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Abstract
Purpose
The overall purpose of this dissertation was to evaluate factors related to reducing length
of stay after total hip and knee arthroplasty (THA and TKA).

Methods
Study 1 was a randomized controlled trial (RCT) to investigate the cost-effectiveness of
outpatient THA compared to standard overnight stay. Study 2 was a prospective cohort
study to assess patient- and caregiver-related factors and how they may relate to caregiver
strain and level of assistance when caring for patients undergoing THA and TKA. Finally,
Study 3 was a 2x2 factorial RCT to compare the trajectory of early functional recovery
between the medial parapatellar and midvastus surgical approaches for TKA. The purpose
of Study 3 was to determine whether the choice of surgical approach should be controlled
for a future randomized trial assessing the cost-effectiveness of outpatient TKA.

Results
For our first study, we found standard overnight stay was dominated by outpatient THA
from both healthcare payer (HCP) and societal cost perspectives. Our net benefit analyses
found outpatient THA to be cost-effective at all willingness-to-pay values from an HCP
perspective and values of $500 or more from a societal perspective. For our second study,
our model of caregiver strain found the amount of assistance provided by caregivers to be
a positive predictor, and female patient sex and caregiver age to be negative predictors.
Our model of caregiver assistance found length of stay to be a positive predictor and time
(post- versus pre-surgery) and female patient and caregiver sex to be negative predictors.
For our third study, we found the trajectory of recovery of pain within the first two weeks
after surgery and stride length to have significant group by time interactions. We also
found baseline outcomes to be a consistent predictor of post-surgery recovery.

Conclusions
ii

Reducing the length of stay in hospital after THA and TKA procedures can be costeffective, does not increase caregiver strain and is associated with a reduction in the
amount of assistance provided by caregivers. We’ve also provided evidence for the use of
either of two commonly used surgical approaches for TKA for a future randomized trial
to further explore outpatient arthroplasty.

Keywords
Length of stay, outpatient, total hip arthroplasty, total knee arthroplasty, cost-effect,
caregiver, strain, gait, medial parapatellar, midvastus, hip, knee, osteoarthritis
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Summary for Lay Audience
Total hip and knee replacements (THR and TKR) are both very successful procedures for
treating severe osteoarthritis. As need for these procedures rises each year, so does the
cost to the Canadian healthcare system. Over the years, one way in which hospitals and
physicians have attempted to mitigate these rising costs is by reducing the length of stay
in hospital after surgery. Within the last decade, many physicians have been able to offer
THR and TKR as an outpatient procedure where patients are released from hospital on the
same day as their surgery. The overall aim of this dissertation was to assess factors related
to reducing length of stay in hospital after THR and TKR.

Study 1 compared the cost-effectiveness of outpatient versus overnight hospital stay after
THR. We found outpatient THR to be both less costly and to provide slightly greater
benefit than standard overnight stay in hospital both when only looking at costs covered
by the public healthcare system and when including additional patient costs (such as time
off work).

Study 2 investigated which patient- and caregiver-related factors were related to caregiver
strain and the amount of assistance provided by caregivers after THR and TKR. We
found that when more assistance was provided, caregivers experienced more strain and
that older caregivers and those caring for female patients experienced less strain. We also
found that caregivers provided more assistance after surgery than before surgery and also
provided more assistance the longer patients stayed in hospital. Female caregivers and
those caring for female patients tended to provide less assistance than male caregivers and
those caring for male patients.

Study 3 compared patient recovery early after surgery for two commonly used surgical
techniques for TKR. Only the recovery of knee pain within the first two weeks after
surgery and stride length were different between groups.
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Chapter 1: Introduction

1.1 Introduction
Total hip and knee arthroplasty (THA and TKA) are successful procedures for the
treatment of severe osteoarthritis of the hip and knee. Currently, THA and TKA are
among the top three inpatient surgeries performed annually in Canada with more than
137,000 surgeries performed in 2018-2019, of which, more than 62,000 were hip
replacements and more than 75,000 were knee replacements (1). These numbers continue
to increase dramatically each year as the population ages and represent a five-year
increase of 20.1% and 22.5% respectively (1). This represents an enormous economic
burden on the Canadian public healthcare payer system with approximately $1.4 billion
spent annually (1). This is not unique to Canada however, with numbers increasing
dramatically worldwide. In Australia, there has been a 99.5% increase in the number of
primary THA performed between 2003 and 2017, and an increase of 151.6% over the
same time period for primary TKA (2). In the US, it’s projected that the number of THA
procedures performed annually will increase by 284%, and by 401% for TKA, by the year
2040 (3).

In an attempt to mitigate the rising costs as well as increase capacity in hospitals for these
procedures, hospitals and physicians have been working to reduce the length of stay in
hospital. Length of stay has been steadily decreasing since total joint arthroplasty (TJA)
was first introduced with the median length of stay for THA in Canada halving from 4
days in 2012-2013 (4) to only 2 days in 2018-2019 (1). However, length of stay varies
greatly across countries, regions and hospitals. For example, in 2018-2019, average
length of stay in Canada for primary THA varied across the provinces with a low of 2.4
days in Ontario and a high of 5.0 days in PEI (1). The same can be said for TKA with a
low of 2.3 days in Nova Scotia and a high of 4.6 days in PEI (1).
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1.2 Outpatient Arthroplasty
Many different approaches have been taken to reduce length of stay with improvements
in pain control after surgery, the introduction of minimally invasive surgical techniques
and the introduction of enhanced recovery pathways. These improvements have led to
THA and TKA being performed on an outpatient basis, where patients are discharged
from hospital on the same day as their procedure. Outpatient arthroplasty has been
gaining in popularity over the last decade. In Canada, there has been a dramatic increase
in the performance of outpatient THA and TKA, with increases of 7.6 times and 1.8 times
respectively, over the last five years (1). Despite this, the increase represents only a
fraction of all THA and TKA, with 99% of all procedures performed in 2018-2019 still
requiring an overnight stay in hospital of at least one night (1). In a previous paper, we
outlined factors which may contribute to the slow adoption of outpatient arthroplasty in
Canada, one of which is a concern for patient safety (5).

While there is an abundance of literature investigating the safety of discharging patients
as outpatients (6–10), there is a distinct lack of high-quality prospective studies. A
previous systematic review published by Pollock et al. (2016) found most studies that
evaluated outpatient arthroplasty to be at moderate or high risk of bias (9). Previous large
studies evaluating safety have often relied on retrospective national databases and have
mostly reported similar complication rates for outpatient THA and TKA when compared
with overnight stay (11–16). One study performed by Nowak and Schemitsch (2019)
however, reported worse outcomes for TKA patients who had a length of stay of zero
days when compared to those with length of stay of two days (17). Only one randomized
trial currently exists in the literature (18). Goyal et al. (2017) randomized patients
undergoing THA to either be discharged as outpatients or to stay overnight in hospital
(18). They found no difference between the groups for reported reoperations or
readmissions, though they acknowledge that their study was not powered to detect
differences in complication rate. This study also reported significant cross-over between
the groups as they allowed participants to switch groups based on personal preference
(18).
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One difficulty with evaluating the current outpatient literature is that various groups
define outpatient differently. While true outpatient surgery involves discharging patients
from hospital on the same day as their procedure, some studies define outpatient as less
than 24-hour stay in hospital, which may include an overnight stay. A study by
Bovonratwet et al. (2017) investigated these definitions using the American College of
Surgeons National Surgical Quality Improvement Program (NSQIP) database, as the
database contains two variables for status, coded only as “inpatient” and “outpatient”, as
well as length of stay (19). With their study, they found that less than 15% of patients
coded as “outpatient” were discharged from hospital on the same day as their procedure
(19). This makes evaluating the published literature difficult, especially when looking at
costs of these procedures, as many studies may be including overnight hospital costs in
their evaluation of outpatient procedures.

Few studies have thus far investigated the proposed cost savings of outpatient arthroplasty
(6,20,21), however all have reported similar results with outpatient TJA resulting in cost
savings compared to overnight stay. A systematic review by Crawford et al. (2015)
evaluated seven studies which compared costs between outpatient and inpatient
procedures (6). These studies reported cost savings between 17.6% and 57.6% for the
outpatient procedures, however only four of the included studies evaluated THA or TKA
(6). All studies thus far have only compared the direct costs of the procedures during the
hospital stay using the perspective of the healthcare payer, however it’s also important to
incorporate costs accrued post-discharge and indirect costs of the procedures to ensure
that costs saved from sending patients home earlier are not simply shifted further down
the recovery pathway. Indirect costs can include time off from work, homemaking or
volunteer activities as well as costs attributed to family members who may be taking time
off from work to care for the patient. No studies as of yet have assessed the cost of
outpatient arthroplasty in conjunction with a randomized trial, and none have included a
full economic evaluation where both costs and effects are investigated simultaneously to
estimate the cost-effectiveness of outpatient TJA.
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1.3 Informal Caregiver Involvement
The importance of spousal and familial involvement in the recovery pathway and
rehabilitation process of THA and TKA patients is growing with the push to shorten
length of stay and introduction of outpatient arthroplasty. Discharging patients from
hospital earlier pushes care activities which normally would be undertaken by nurses and
other healthcare professionals in hospital onto these caregivers. As these informal
caregivers become more involved earlier in the care pathway, it’s important to consider
their perspectives to ensure that they are adequately equipped to help patients. Caregivers
of arthroplasty patients have not commonly been included in research thus far with few
published papers investigating impacts to these caregivers (22–30). A previous study at
our institution by Churchill et al. (2018) qualitatively assessed the impact of outpatient
discharge after THA on both patients and their informal caregivers (30). According to the
patients they interviewed, they viewed their caregivers’ support as essential to their
recovery and supporting their transition home. They also reported that their caregivers
provided extensive assistance in regard to both mobility and self-care (30).

Existing studies are primarily qualitative in nature (23,25–27,30–32) and were focused on
education and the fulfilment of knowledge expectations (23,26). While these areas are
important to consider, it’s also vital to understand who these informal caregivers are, how
much care and assistance they are providing, and the burden or strain they may be
experiencing. One previous study, by Zadzilka et al. (2018), quantitatively investigated
patient- and caregiver-related factors which may be related to caregiver burden when
caring for TKA patients (22). They reported that patient and caregiver sex, race and
employment status, caregiver age and education level, patient knee-related quality of life
and both patient and caregiver mental component scores from the Veterans RAND 12
Item Health Survey (VR-12) were significantly correlated with caregiver strain four
weeks after surgery (22). Better understanding of these patient- and caregiver-related
factors can help guide future education efforts, as it can provide information as to who
most needs and would most benefit from additional training or education.
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1.4 Surgical Approach
In both THA and TKA, many surgical approaches have been adopted over the years with
the aim of improving postoperative outcomes and reducing length of stay. In regard to
TKA specifically, while there has been a lot of research comparing alternative surgical
approaches, postoperative outcomes were similar among approaches. Two such
approaches, the medial parapatellar and midvastus, have been compared in several
previously published meta-analyses (33–36). The medial parapatellar approach is familiar
to most orthopaedic surgeons and is widely utilized. This surgical approach provides
excellent exposure of the knee joint but involves disrupting the extensor mechanism (37).
The midvastus approach on the other hand, is relatively newer and thus less familiar,
however a proposed advantage of the approach is that is spares the majority of the vastus
medialis insertion on the quadriceps tendon (37). It’s proposed that the midvastus
approach may provide some advantages over the medial parapatellar approach in terms of
accelerated rehabilitation and shorter hospital stay, however this has yet to be borne out in
the literature.

The previously mentioned meta-analyses have focused on comparing surgical and patientreported outcomes between the two approaches (33–36). These studies reported less pain
early in the postoperative period, within the first two weeks, and improved range of
motion for the midvastus approach (33,34,36), but also longer operative times (33–36).
None of the studies have reported advantages of the midvastus approach later than two
weeks after surgery (33–36).

Few studies have compared functional outcomes between these two approaches. One
study conducted by Nutton et al. (2014) reported no statistically or clinically significant
differences between the groups when comparing time to complete the Timed Up and Go
(TUG) test, walking speed, or knee extensor strength, among other outcomes up to six
months after surgery (38). Pethes et al. (2014) however, reported faster recovery towards
normal values for the midvastus approach for all gait outcomes measured at six- and 12weeks including cadence, knee motion and pelvic and shoulder tilt and rotation when
compared with the medial parapatellar approach (39). No studies have yet compared the
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medial parapatellar and midvastus surgical approaches for gait outcomes earlier than six
weeks after surgery. The midvastus approach may be advantageous for functional
recovery in the early postoperative period as the extensor mechanism is left intact, which
could translate to shorter length of stay in hospital, faster rehabilitation and achievement
of functional milestones in the recovery of independent mobility.

1.5 Purpose
The overall purpose of this dissertation was to assess factors related to reducing length of
stay after total hip and knee arthroplasty. I achieved this purpose by undertaking three
distinct research studies. Study 1 was a randomized trial to investigate the costeffectiveness of outpatient discharge compared to standard overnight stay in hospital after
THA. Study 2 was a cohort study involving the informal caregivers of THA and TKA
patients to assess how patient- and caregiver-related factors influence caregiver strain and
level of assistance. Study 3 was a randomized trial to compare the trajectory of early
functional recovery between the medial parapatellar and midvastus surgical approaches
for TKA. The purpose of Study 3 was to determine whether the choice of surgical
approach should be controlled for a future randomized trial assessing the costeffectiveness of outpatient TKA. I used an integrated article format for this dissertation,
as such, some of the information provided in this introduction will be repeated in the
following chapters.
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Chapter 2: A randomized trial to investigate the cost-effectiveness
of outpatient total hip arthroplasty
2.1 Abstract
Background
Total hip arthroplasty (THA) is an effective surgery for the treatment of advanced
osteoarthritis but increasing numbers of these procedures are having a significant impact
on healthcare budgets. One route to mitigate the increasing costs is outpatient THA,
discharging patients on the same day as their surgery. The purpose of this study was to
evaluate the cost-effectiveness of outpatient THA compared to standard overnight stay in
hospital from healthcare payer and societal perspectives.

Methods
We conducted a prospective randomized controlled trial for patients undergoing primary
THA through a direct anterior approach. Participants were randomized to be discharged
on the same day as surgery, outpatient group, or on day one post-surgery, inpatient group,
using a modified Zelen consent model. Adverse events were recorded, participants
completed self-reported cost questionnaires at two-, six- and 12-weeks post-surgery, and
the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) presurgery and at 12-weeks post-surgery. We performed a cost-effectiveness analysis from
health care payer (HCP) and societal perspectives using the WOMAC total score as the
measure of effect.

Results
One hundred and five participants completed the study, with 49 randomized to outpatient
and 56 randomized to inpatient THA. Seven participants from the outpatient group and
five participants from the inpatient group crossed over. Adverse event rate was similar
between the groups with seven events in four participants in the inpatient group, and three
events in two participants in the outpatient group. From both an HCP and societal
perspective, inpatient THA was dominated by outpatient THA. The cost difference was -
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$1,024.24 (95% CI -2170.80, 122.31, p=0.080) for HCP and -$1,746.21 (95% CI 3719.62, 227.19, p=0.083) for societal in favour of outpatient THA. Net benefit analyses
found outpatient THA to be cost-effective at all willingness-to-pay values from an HCP
perspective, and at values of $500 or greater from a societal perspective. WOMAC total
scores and function subscale scores were higher for the outpatient group at 12-weeks
(mean difference 2.3 (95% CI 0.4, 4.2), p=0.015 and 7.0 (95% CI 0.6, 13.5), p=0.033
respectively).

Conclusions
Our results suggest that outpatient THA is a cost-effective procedure when compared to
inpatient THA from an HCP perspective when willing to pay any amount, and from a
societal perspective when willing to pay at least $500 for a one-point improvement in the
WOMAC total score. We will continue recruitment to investigate whether these results
hold true in a larger sample as well as assess for patient safety and satisfaction.
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2.2 Introduction
Total hip arthroplasty (THA) is an effective surgery for the treatment of advanced
osteoarthritis of the hip. The number of these procedures performed in Canada increased
by 17.8% between 2012-13 and 2016-17 (1). This increase has a significant impact on
healthcare budgets and highlights the critical need to improve care delivery. To mitigate
the rising costs, outpatient THA (discharging patients on the same day as their surgery)
has been introduced yet high quality evidence to support the use of outpatient THA is
lacking. Significant cost savings are proposed for outpatient procedures as they eliminate
the need for overnight stay with the associated nursing, pharmacy and inpatient costs
(2,3).

Many studies have been published evaluating the safety of outpatient THA (4-8),
including several reviews of US national databases (9-14), which have all found
outpatient THA to have similar complication rates to inpatient procedures. Most
prospective studies that have investigated outpatient THA have included carefully
selected patient populations (3,15-19) and used observational cohort designs (4-7), thus
limiting the generalizability and strength of the evidence. Only one study, conducted by
Goyal et al. in 2017, has used a randomized study design and while this is an
improvement from non-randomized, observational designs, the study demonstrated
significant cross-over between the groups as they allowed participants to switch groups
based on personal preference (20).

Few studies have investigated economic implications (2,3), and none have prospectively
investigated costs in conjunction with a randomized controlled trial. Both studies which
investigated costs found outpatient THA to be cost saving (2,3). Of these studies, one was
a pilot study comparing the cost of a prospective cohort of only 10 outpatients to a
matched cohort of inpatients (2). Another study was also an observational case-control
study, but included a total of 119 outpatients, all of whom underwent a direct anterior
surgical approach (3). Both studies only investigated direct costs of the procedures using
a healthcare payer perspective. Importantly, indirect costs of the procedures were not
investigated in these studies, and both only included costs incurred during the hospital
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stay with no costs accounted for post-discharge (2,3). Using a broader perspective which
includes indirect costs is important for the evaluation of outpatient THA to ensure that
costs possibly saved from reduced hospital stay are not shifted further along the recovery
pathway. Indirect costs can include time off from paid employment, homemaking,
volunteer activities, or caregiving. As the population of patients eligible for outpatient
discharge tend to be younger (5) and still in the workforce, it’s important to take these
costs into consideration. Indirect costs attributed to patients’ caregivers is also important
to consider as sending patients home earlier could result in greater caregiver involvement
and their own time off work. Costs associated with possible post-operative complications
should also be accounted for in a cost analysis. Finally, no studies to date have conducted
a full economic evaluation evaluating both costs and effects together to investigate the
cost-effectiveness of outpatient THA.

The purpose of this study was to investigate the cost-effectiveness of outpatient THA
compared to inpatient (standard overnight stay in hospital) from healthcare payer and
societal perspectives. We hypothesized that outpatient THA would be cost-effective
compared to inpatient THA from both perspectives.

2.3 Materials and Methods
We conducted a randomized trial to compare patients discharged from hospital after THA
as outpatients to standard overnight stay (inpatients). All patients underwent THA
through a direct anterior surgical approach, which has a standard length of stay of one day
at our institution. This paper represents a preliminary analysis of patients who underwent
surgery between June 2015 and November 2017. This study was conducted at a single
centre, among patients of one fellowship trained arthroplasty surgeon and was approved
by our institution’s Research Ethics Board and registered at www.ClinicalTrials.gov
(NCT03026764).

2.3.1

Selection Criteria

Participants were included if they were undergoing primary THA with an ASA status less
than or equal to three, were able to read and understand English, lived within a 60-minute
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driving distance of the hospital, had home or cell phone access and had an adult caregiver
to accompany them home post-surgery. Participants were excluded if they had been
diagnosed with fibromyalgia, were skeletally immature, had an active or suspected latent
infection in or about the joint, had bone stock inadequate for support or fixation of the
prosthesis, were unable to go to their home after surgery, had cognitive or neuromotor
conditions, significant pain management issues, family history of anaesthesia-related
complications, obesity that significantly impacted their ability to mobilize, anaphylaxis to
penicillin, significant psycho/social issues that would prevent the patient from managing
at home safely or were narcotic dependent.

2.3.2

Randomization

Participants were enrolled at consultation for surgery and were randomized via a webbased randomization system a minimum of three months prior to surgery. Randomization
was stratified by previous experience with THA (whether themselves, or a family
member they cared for post-surgery). Participants were randomly allocated in a one-toone ratio to either outpatient or inpatient THA using a modified Zelen consent model (21)
to minimize the risk of bias associated with knowledge of the alternative intervention. We
used this model because we posited that patients with a strong preference for overnight
care who were randomized to the outpatient group may have been more likely to return to
seek additional care significantly biasing costs. Alternatively, patients with a strong
preference for outpatient care who were randomized to the inpatient group may have
biased measures of satisfaction. Thus, for this study, we asked participants to consent to
all aspects of the study protocol with the exception of randomization; participants were
not told about randomization, the existence of an alternative group, or the between-groups
objectives. At the final study visit, we disclosed the full nature of the study to the
participants, why blinded randomization was necessary and sought consent to include
their data in the analysis.

2.3.3

Outcome Assessment

Assessments were completed prior to surgery, at discharge from the hospital and at two-,
six- and 12-weeks post-surgery. Adverse events were recorded at each study visit and
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surgical characteristics were recorded (including change in haemoglobin, surgical time
and length of stay in hospital).

Participants completed the Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC) prior to surgery and at 12-weeks post-surgery. The WOMAC is a
patient-reported outcome measure that evaluates function and includes pain, stiffness and
function subscales with higher scores indicating better function and has previously been
found to be valid for use in assessing hip arthroplasty patients (22).

2.3.4

Resource Use

Patients completed a self-reported cost questionnaire at two-, six- and 12-weeks postsurgery. Costs collected included visits to emergency rooms, specialists, family doctor,
outpatient clinics and other healthcare professionals (such as physical therapists,
occupational therapists, etc.). We also collected information about hospitalizations, tests,
procedures, additional surgeries, medications and calls to the surgeon’s office, or resident
on call. All direct costs (such as visits to their surgeon) were obtained from the Ontario
Ministry of Health Schedule of Benefits (23), and medication costs were obtained from
the Ontario Drug Benefit Formulary/Comparative Drug Index (24). We valued calls to the
surgeon’s office, or resident on call, that lasted at least 10 minutes, the same as a partial
assessment from the Ontario Ministry of Health Schedule of Benefits (23). If patients
reported that they paid for other healthcare professional visits out-of-pocket or via private
insurance, we used their self-reported costs per visit.

We also collected information about indirect costs such as employment status and timeoff paid employment, homemaking, volunteer activities and caregiving (i.e. taking care of
dependents), as well as hours of assistance received from friends or family (including
caregivers who stayed with patients post-surgery). To evaluate the cost related to time-off
paid employment, we used the self-reported annual household income to calculate the
average wage per day and, using self-reported days off work, calculated the total wages
lost. For our base case analysis, we did not assign a monetary value to time-off
homemaking, volunteer activities, caregiving and caregiver assistance.
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Direct costs associated with the surgical procedure were obtained from our institution
(25), while direct costs of other related procedures (e.g. irrigation and debridement) were
obtained from the Ontario Case Costing Initiative (26). These costs included those related
to implants, equipment, operating room, nursing, pharmacy, medicine as well as length of
stay in hospital. Time spent in each department of the hospital post-surgery (postanaesthesia care unit [PACU], recovery or inpatient ward) was recorded during the study
and costs per unit time spent in each area was provided by our institution.
Anesthesiologist and surgeon billing fees were reported from the Ontario Ministry of
Health Schedule of Benefits (23). We estimated the total cost for each participant over
their 12-week involvement in the study and reported all costs in 2019 Canadian dollars.

2.3.5

Statistical Analysis

We completed our data analysis using Stata/IC version 16.1 (StataCorp LLC 2019)
software. We conducted our primary analysis following the intention-to-treat principle.
We used descriptive statistics to present the demographic characteristics of the treatment
groups using means and standard deviations for continuous variables (age, body mass
index (BMI), height, weight) and proportions for nominal variables (sex, operative hip,
smoking status, contralateral THA). We tested all outcomes for normality and
distribution, and if skewed, all comparisons were based on bootstrapped standard errors
and 95% confidence intervals (CI). We used non-parametric bootstrapping with 100
replications.

We imputed missing data using multiple imputation with chained equations (MICE). We
used predictive mean matching pulling from five nearest neighbours and included seven
iterations with group (both according to intention-to-treat and as treated), smoking status
(yes or no), BMI, previous THA (yes or no), age and sex used as covariates in the MICE
model.
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We compared cost and WOMAC scores (total and each subscale at baseline and 12
weeks) between the groups using linear regression with group as the predictor. For the
analysis of 12-week WOMAC scores, we also included baseline scores as a covariate.

2.3.5.1 Cost-Effectiveness Analyses
We performed a cost-effectiveness analysis from both healthcare payer (HCP) and
societal perspectives. The HCP perspective included direct costs (visits to healthcare
professionals, procedures, medications, tests, hospitalizations and visits to emergency
rooms) while the societal perspective included both direct and indirect costs (time-off
paid employment, volunteer activities, homemaking, caregiving and caregiver assistance)
as well as out-of-pocket expenses to patients. We used the WOMAC total score as our
measure of effect to calculate the incremental cost-effectiveness ratio (ICER) at 12-weeks
post-surgery for each perspective. ICERs were calculated by taking the ratio of the
difference in cost by the difference in effect between groups. Discounting was not used
for cost or effect as the time horizon for the study was less than one year.

We also used net benefit regression (NBR) to estimate the cost-effectiveness of outpatient
THA compared to standard inpatient care. This allowed us to consider the incremental
cost and effect of the intervention using a willingness-to-pay (WTP) value (maximum
amount one would be willing to pay for one additional unit improvement in effect). Using
this framework, an intervention is considered to be cost-effective when the incremental
net benefit (INB) is greater than zero:
INB = (WTP * ΔE) – ΔC
where ΔE is the difference in effect, and ΔC is the difference in cost, between the
outpatient and inpatient groups. We reported the uncertainty around our estimate using
95% CI around the INB.

We performed the NBR from both perspectives using WTP values varied between $0 and
$2,000. Age, sex, BMI and baseline WOMAC total score were used as covariates in the
NBR models. Uncertainty was presented graphically with cost-effectiveness acceptability
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curves (CEAC). The CEAC displays the probability that outpatient THA is cost-effective
compared to standard inpatient care over the range of WTP values.

2.3.5.2 Sensitivity Analyses
We performed six one-way sensitivity analyses and presented the results in the CEAC
along with the results of the base case analysis.
•

Valuing participants’ unpaid time-off (including time-off caregiving, homemaking
and volunteer work) at minimum wage in Ontario, $14 per hour (27).

•

Valuing caregiver assistance time at minimum wage in Ontario, $14 per hour (27).

•

Analyzing participants who crossed over as treated from the (a) HCP perspective
and (b) societal perspective.

•

Outliers (residuals > 2) removed to assess how these affected our results from the
(a) HCP perspective and (b) societal perspective.

2.4 Source of Funding
This study was supported by the Opportunities Fund of the Academic Health Sciences
Centre Alternative Funding Plan of the Academic Medical Organization of Southwestern
Ontario (AMOSO). We also received funding from the Physicians’ Services Incorporated
(PSI) Foundation. Neither funding source played a role in how the study was conducted.

2.5 Results
One hundred and twenty-five patients were prospectively enrolled, and 105 completed the
12-week follow-up and were included in the analysis (49 outpatients and 56 inpatients)
(Figure 2-1). Seven participants from the outpatient group crossed over and stayed at least
one night in hospital while five participants in the inpatient group crossed over and went
home on the same day as surgery. Reasons for cross-over in the outpatient group included
pain (1), inability to pass physiotherapy discharge criteria (2), decreased oxygen levels
requiring overnight monitoring (1), wound concerns (1) and intraoperative cardiac issues
(1). Participants crossed over from the inpatient to outpatient group because they met the
discharge criteria and hospital staff, who were unaware of study group allocation, sent
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them home. No participants were unblinded prior to the debriefing discussion at 12 weeks
post-surgery and only one participant declined to sign the debriefing consent and
therefore had their data excluded from the analysis. We had seven percent missing data
for the study.

Figure 2-1. CONSORT diagram of participant flow through the study.
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Demographic and surgical characteristics were similar between groups with the exception
of change in haemoglobin (Table 2-1 and 2-2). Length of stay in the outpatient group was
20.3 hours (95% CI 10.4, 30.1) less, on average, compared to inpatients in our intentionto-treat analysis (Table 2-2). When participants who crossed over were analyzed as
treated, the average length of stay in the outpatient group was 8.8 hours (SD 1.2) and 39.3
(SD 30.1) hours in the inpatient group.

Table 2-1. Participant demographics.
Characteristic

Inpatient (n=56)

Outpatient (n=49)

Height  SD, in

67.2  3.4

67.6  3.8

Weight  SD, lb

175.7  40.0

172.7  37.9

BMI  SD, kg/m2

27.2  5.0

26.3  4.1

Age  SD, y

63.6  10.4

64.6  9.4

Sex (Male), n (%)

27 (48)

27 (55)

Contralateral Hip Symptoms, n (%)

18 (32)

13 (27)

Contralateral THA, n (%)

9 (16)

12 (24)

Smokers, n (%)

4 (7)

5 (10)

1

7 (13)

7 (14)

2

27 (48)

27 (55)

3

22 (39)

14 (29)

0

41 (73)

40 (82)

1

14 (25)

8 (16)

2

1 (2)

1 (2)

ASA Score, n (%)

Charlson Comorbidity Index, n (%)

Abbreviations. SD = standard deviation, BMI = body mass index.
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Table 2-2. Surgical and length of stay information
Parameters

Inpatient

Outpatient

Mean Difference

Mean (SD)

Mean (SD)

(95% CI)

Change in Haemoglobin, mmHg

-25.8 (9.1)

-14.5 (6.4)

-11.2 (-14.3, -8.1)

Operative Time, min

69.3 (14.0)

72.4 (21.3)

-3.1 (-10.0, 3.8)

Length of Stay, hrs

35.1 (27.7)

14.9 (22.1)

Admission to PACU, hrs

4.5 (1.0)

3.7 (0.6)

0.8 (0.4, 1.1)

Time in PACU, hrs

2.6 (1.7)

2.3 (1.6)

0.2 (-0.4, 0.9)

28.0 (28.4)

8.2 (21.5)

19.8 (9.5, 30.2)

PACU to Discharge, hrs

Abbreviations. SE = standard error, CI = confidence interval, PACU = post anaesthesia
care unit.

Time from admission to PACU was shorter in the outpatient group as was time from
recovery or inpatient ward to discharge as expected (Table 2-2). Time in PACU was
similar between the groups when analyzed per intention-to-treat but was shorter in the
outpatient group when analyzed as treated (mean difference 0.8hrs, 95% CI 0.2, 1.5,
p=0.015).

There was one significant outlier in each group with length of stay greater than 150 hours.
The outlier in the outpatient group remained in hospital for 151.2 hours due to increased
oxygen requirements and drowsiness post-surgery thought to be due to post-surgery
narcotic use and medication interactions. The outlier in the inpatient group remained in
hospital for 218.6 hours due to an intraoperative femoral fracture for which they were
kept non-weightbearing post-surgery and remained in hospital while awaiting a bed
opening in a Transitional Care Unit.

2.5.1

Adverse Events

The rate of adverse events was similar between the groups with seven events in four
participants in the inpatient group and three events in two participants in the outpatient
group (Table 2-3). Only one adverse event in the outpatient group was possibly related to
the timing of discharge, an analgesia overdose. This participant presented to the
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emergency department by ambulance after suffering an overdose two days after surgery
from misunderstanding their analgesia prescription, which resolved uneventfully.
Important events in the inpatient group included one patient requiring a closed reduction
six weeks after surgery and one deep infection treated with irrigation and debridement
with head and liner exchange three weeks after surgery. Both events resolved
uneventfully by 12 weeks post-surgery.

Table 2-3. Adverse events for overnight and outpatient total hip arthroplasty.
Adverse Event

Major Complications

Minor Complications

Inpatient

Outpatient

(n=56)

(n=49)

Dislocation

1

0

Intraoperative Fracture

1

0

Deep Infection

1

0

Analgesia Overdose

0

1

Superficial Infection

1

1

Urinary Tract Infection

1

0

Fall

1

0

0

1

1

0

Medical Complications Atrial Flutter
Atrial Fibrillation
Total

2.5.2

7 (in 4 patients) 3 (in 2 patients)

Patient Reported Outcomes

WOMAC total scores and function subscale scores were higher for the outpatient group at
12 weeks compared to the inpatient group (Table 2-4). All other WOMAC scores were
similar between the groups (Table 2-4).
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Table 2-4. WOMAC subscale and total scores measured at baseline and 12 weeks
postoperative.
Outcome

Inpatient

Outpatient

Mean Difference

Mean (SD)

Mean (SD)

(95% CI)

Baseline

83.1 (6.2)

81.5 (4.9)

-1.7 (-3.8, 0.3)

12 Weeks

95.0 (6.1)

96.5 (3.7)

2.3 (0.4, 4.2)

Baseline

52.3 (17.9)

48.2 (17.6)

-4.3 (-11.4, 2.8)

12 Weeks

87.9 (17.0)

90.4 (13.0)

3.6 (-2.4, 9.5)

Baseline

45.9 (18.3)

40.6 (17.0)

-5.5 (-12.4, 1.3)

12 Weeks

79.0 (21.6)

80.7 (17.5)

5.1 (-1.8, 12.0)

Baseline

52.3 (18.4)

47.6 (14.3)

-4.9 (-10.8, 1.0)

12 Weeks

85.6 (18.5)

90.5 (9.9)

7.0 (0.6, 13.5)

WOMAC Total

WOMAC Pain

WOMAC Stiffness

WOMAC Function

Abbreviations. SE = standard error, CI = confidence interval.

Costs reported by participants over the course of the study are summarized in Table 2-5.
Costs were less in the outpatient group compared to the inpatient group from both HCP
and societal perspectives (Table 2-6).
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Table 2-5. Costs reported by participants over the 12-week study period (in Canadian
dollars).
Costs

Inpatient

Outpatient

Mean (SD)

Mean (SD)

6447.36

6447.36

PACU

306.56 (192.41)

275.96 (181.72)

Day Surgery

35.90 (117.87)

285.20 (169.05)

Ward

838.33 (857.47)

186.12 (659.77)

Total Hospital Costs

7628.15 (805.14)

7194.64 (690.71)

Physician

82.71 (404.47)

17.33 (36.16)

Physiotherapy1

346.21 (246.28)

312.80 (166.06)

Occupational Therapy1

11.79 (49.99)

15.71 (77.78)

Other1

2.23 (16.70)

0

454.11 (472.01)

334.41 (175.36)

Medication1

51.94 (75.56)

71.45 (96.85)

Tests and X-Rays

47.94 (5.77)

44.99 (2.45)

610.63 (3250.04)

70.78 (157.97)

242.80 (34.83)

148.98 (24.36)

Time-off Paid Employment

3368.88 (5407.51)

2792.98 (4701.20)

Time-off Volunteer Activities2

446.00 (1540.19)

36.57 (225.61)

Time-off Homemaking2

1278.00 (1663.76)

717.43 (1020.86)

Time-off Caregiving2

0

116.57 (370.02)

Caregiver Assistance2

693.65 (789.64)

619.39 (817.14)

Hospital Costs
Procedure

Health Care Provider

Total Healthcare Provider Costs1

Emergency Visits and Hospitalizations
Other Out-of-Pocket Expenses
Indirect Costs

Abbreviations. SD = standard deviation.
1

Given the Canadian healthcare system, some medical costs were partially covered by the healthcare payer,

private insurance or were paid out of pocket by the patient. Therefore, only some of the medication costs or
physiotherapy costs, for example, would be included in the healthcare payer perspective.
2

Valued at $14/hr
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Table 2-6. Costs from healthcare payer and societal perspectives with sensitivity analyses over the course of the 12-week study (in
Canadian dollars).
Scenario

Inpatient

Outpatient

Mean Difference

Mean (SD)

Mean (SD)

(95% CI)

Base Case

8666.80 (3956.78)

7642.55 (753.33)

-1024.24 (-2170.80, 122.31)

As Treated

8790.55 (3893.38)

7446.24 (276.17)

-1344.31 (-2408.65, -279.97)

Outliers Removed

7919.03 (416.58)

7642.55 (753.33)

-276.48 (-487.01, -65.95)

Base Case

12404.44 (6256.56)

10658.23 (4695.54)

-1746.21 (-3719.62, 227.19)

As Treated

11981.70 (5830.95)

11105.60 (5383.19)

-876.10 (-2759.43, 1007.23)

Outliers Removed

11051.30 (3912.64)

10078.10 (3814.94)

-973.20 (-2358.60, 412.20)

Unpaid Time-Off Included

14128.44 (7157.75)

11528.80 (5040.32)

-2599.64 (-4848.03, -351.25)

Caregiver Assistance Included

14822.09 (7175.00)

12148.19 (5278.08)

-2673.89 (-4938.50, -409.29)

Healthcare Payer Perspective

Societal Perspective

Abbreviations. SD = standard deviation, CI = confidence interval.
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2.5.3

Cost-Effectiveness

ICERs were not calculated as the inpatient group was dominated by the outpatient group
for both perspectives, meaning that outpatient THA was both less expensive and more
effective (Table 2-7). While the difference in effect, total WOMAC score, was
significantly different between the groups in favour of the outpatient group, the difference
did not include a minimally clinically important difference (MCID) (reported as at least
five points) (28,29).

Table 2-7. Incremental cost-effectiveness of outpatient total hip arthroplasty compared to
standard overnight stay.
Scenario

Incremental Cost

Incremental Effect

ICER

(95% CI)

(95% CI)

Base Case

-1024.24 (-2170.80, 122.31)

2.3 (0.4, 4.2)

Dominated

As Treated

-1344.31 (-2408.65, -279.97)

2.3 (0.4, 4.2)

Dominated

-276.48 (-487.01, -65.95)

2.3 (0.4, 4.2)

Dominated

Base Case

-1746.21 (-3179.62, 227.19)

2.3 (0.4, 4.2)

Dominated

As Treated

-876.10 (-2759.43, 1007.23)

2.3 (0.4, 4.2)

Dominated

Outliers Removed

-973.20 (-2358.60, 412.20)

2.3 (0.4, 4.2)

Dominated

-2599.64 (-4848.03, -351.25)

2.3 (0.4, 4.2)

Dominated

Caregiver Assistance Included -2673.89 (-4938.50, -409.29)

2.3 (0.4, 4.2)

Dominated

Healthcare Payer Perspective

Outliers Removed
Societal Perspective

Unpaid Time-Off Included

Abbreviations. CI = confidence interval, ICER = incremental cost-effectiveness ratio.

For the NBR, outpatient THA was cost-effective compared to inpatient THA from an
HCP perspective for all WTP values (INB>0, Table 2-8 and Figure 2-2a). From a societal
perspective, results were inconclusive at WTP values of $250 or less, but at WTP values
of $500 or greater, outpatient THA was cost-effective (INB>0, Table 2-8 and Figure 22b).
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Figure 2-2. Cost-effectiveness acceptability curves (CEAC) presenting the probability that outpatient total hip arthroplasty is costeffective compared to standard inpatient care from (a) healthcare payer and (b) societal perspectives at various willingness-to-pay
values (in Canadian dollars) for a one-unit improvement in total WOMAC score at 12 weeks postoperative.
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Table 2-8. Net benefit regression results from both healthcare payer and societal
perspectives using willingness-to-pay values varied between $0 and $2,000 (in Canadian
dollars).
WTP

Healthcare Payer

Societal

INB (SE)

95% CI

p-Value

INB (SE)

95% CI

p-Value

0

1123 (539)

68, 2179

0.04

1451 (1049)

-606, 3507

0.17

250

1748 (601)

570, 2925

<0.01

2075 (1081)

-45, 4194

0.06

500

2372 (751)

899, 3844

<0.01

2699 (1171)

404, 4993

0.02

750

2996 (949)

1136, 4856

<0.01

3323 (1305)

764, 5881

0.01

1000

3620 (1170)

1326, 5914

<0.01

3947 (1473)

1060, 6834

0.01

1250

4244 (1404)

1493, 6996

<0.01

4571 (1664)

1310, 7833

0.01

1500

4868 (1645)

1645, 8092

<0.01

5195 (1871)

1528, 8862

0.01

1750

5492 (1890)

1789, 9196

<0.01

5819 (2089)

1725, 9914

0.01

2000

6116 (2138)

1926, 10306

<0.01

6444 (2315)

1906, 10982

0.01

Abbreviations. WTP = willingness-to-pay value, INB = incremental net benefit, SE =
standard error, CI = confidence interval.

2.5.4

Sensitivity Analyses

The inpatient group remained dominated by the outpatient group for all sensitivity
analyses (Table 2-7).
Sensitivity analyses which included valuing participants’ unpaid time-off from volunteer,
homemaking and caregiving activities, and caregiver assistance at minimum wage
resulted in lower costs in favour of the outpatient group (Table 2-6). For the NBR, results
changed when adding unpaid time-off from volunteer, homemaking and caregiving
activities, as results were inconclusive at a WTP value of $0 and outpatient THA was
cost-effective at WTP values of $250 or greater (INB>0, Table 2-9 and Figure 2-2b).
When caregiver assistance was included, outpatient THA was cost-effective at all WTP
values (INB>0, Table 2-9 and Figure 2-2b).
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Table 2-9. Net benefit regression results for sensitivity analyses from a societal
perspective analyzing (1) participants who crossed over as treated, (2) with outliers
removed, (3) with participants’ unpaid time-off volunteer, homemaking and caregiving
included and (4) with caregiver assistance included, using willingness-to-pay values
varied between $0 and $2,000 (in Canadian dollars).
WTP

As Treated

Outliers Removed

INB (SE)

95% CI

p-Value

INB (SE)

95% CI

p-Value

0

747 (1032)

-1276, 2770

0.47

720 (610)

-476, 1917

0.24

250

1460 (1097)

-690, 3611

0.18

1289 (677)

-38, 2615

0.06

500

2174 (1224)

-226, 4574

0.08

1857 (827)

236, 3478

0.03

750

2887 (1397)

150, 5625

0.04

2425 (1024)

418, 4433

0.02

1000

3601 (1600)

466, 6737

0.02

2993 (1247)

550, 5437

0.02

1250

4315 (1823)

741, 7888

0.02

3562 (1483)

655, 6469

0.02

1500

5028 (2061)

990, 9067

0.02

4130 (1728)

744, 7516

0.02

1750

5742 (2307)

1219, 10264

0.01

4698 (1977)

823, 8574

0.02

2000

6455 (2561)

1436, 11475

0.01

5267 (2230)

895, 9638

0.02

WTP

Unpaid Time-Off Included

Caregiver Assistance Included

INB (SE)

95% CI

p-Value

INB (SE)

95% CI

p-Value

0

2348 (1217)

-38, 4734

0.05

2449 (1226)

46, 4851

0.05

250

2972 (1266)

491, 5454

0.02

3073 (1281)

563, 5583

0.02

500

3597 (1363)

925, 6268

0.01

3697 (1382)

988, 6406

0.01

750

4221 (1498)

1285, 7157

0.01

4321 (1521)

1341, 7302

<0.01

1000

4845 (1662)

1587, 8103

<0.01

4945 (1688)

1638, 8253

<0.01

1250

5469 (1848)

1847, 9091

<0.01

5569 (1875)

1895, 9244

<0.01

1500

6093 (2049)

2077, 10110

<0.01

6194 (2077)

2122, 10265

<0.01

1750

6717 (2262)

2284, 11151

<0.01

6818 (2291)

2327, 11308

<0.01

2000

7341 (2483)

2474, 12208

<0.01

7442 (2513)

2517, 12367

<0.01

Abbreviations. WTP = willingness-to-pay value, INB = incremental net benefit, SE =
standard error, CI = confidence interval.
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When analyzing the participants who crossed over as treated, the difference in costs
between the groups was less compared to the base case from a societal perspective, but
with a similarly wide CI. From an HCP perspective, there was a larger difference in cost
between the groups in favour of the outpatient group (Table 2-6). The NBR results did not
change from an HCP perspective when the groups were analyzed as treated (Table 2-9, 210 and Figure 2-2a). From a societal perspective, results were inconclusive for WTP
values of $500 or less and outpatient THA was determined to be cost-effective at all WTP
values of $750 or greater (INB>0, Tables 2-9, 2-10 and Figure 2-2b).

Table 2-10. Net benefit regression results for sensitivity analyses from a healthcare payer
perspective analyzing (1) participants who crossed over as treated and (2) with outliers
removed, using willingness-to-pay values varied between $0 and $2,000 (in Canadian
dollars).
WTP

As Treated

Outliers Removed

INB (SE)

95% CI

p-Value

INB (SE)

95% CI

p-Value

0

1313 (482)

369, 2258

0.01

303 (106)

96, 510

<0.01

250

2027 (608)

836, 3218

<0.01

840 (321)

211, 1468

0.01

500

2741 (814)

1145, 4336

<0.01

1377 (581)

237, 2516

0.02

750

3454 (1055)

1387, 5521

<0.01

1914 (846)

255, 3572

0.02

1000

4168 (1311)

1598, 6737

<0.01

2451 (1113)

270, 4631

0.03

1250

4881 (1575)

1793, 7969

<0.01

2987 (1380)

284, 5691

0.03

1500

5595 (1844)

1980, 9210

<0.01

3524 (1647)

297, 6752

0.03

1750

6308 (2116)

2161, 10456

<0.01

4061 (1914)

310, 7813

0.03

2000

7022 (2390)

2338, 11706

<0.01

4598 (2181)

323, 8874

0.04

Abbreviations. WTP = willingness-to-pay value, INB = incremental net benefit, SE =
standard error, CI = confidence interval.

There were two outliers with residuals greater than two from the HCP perspective, both
of whom belonged to the inpatient group. When removed from the analysis, the
difference in costs between the groups was less than that from the base case analysis,
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however the 95% CI was also much narrower, giving us greater certainty in our estimate
(Table 2-6). From the NBR, outpatient THA was determined to be cost-effective at all
WTP values (INB>0, Table 2-10 and Figure 2-2a). For the societal perspective, there
were six outliers with residuals greater than two, four of whom belonged to the inpatient
group and two to the outpatient group. When removed from the analysis there was no
change to the cost results or the NBR (Tables 2-6, 2-9 and Figure 2-2b).

2.6 Discussion
This study suggests the cost-effectiveness of outpatient compared to inpatient THA at all
WTP values from an HCP perspective and at WTP values of $500 from a societal
perspective.

When looking at our cost comparisons between the groups, our study found similar
results to other cost analyses reported in the literature. A systematic review conducted by
Crawford et al. (2015) reported cost savings for hip and knee arthroplasty between 17.6%
and 57.6% for outpatient procedures relative to inpatient (4). Our study found cost
savings of 12% and 14% from HCP and societal perspectives respectively in our base
case analyses. Studies that investigated costs in the US report overall higher associated
costs for procedures and greater differences in costs between outpatient and inpatient
THA. Bertin et al. (2005) reported mean savings of over $4,000 USD for outpatient THA
(2) while Aynardi et al. (2014) compared direct anterior THA performed at an outpatient
centre to an inpatient hospital and reported mean savings of almost $7,000 USD (3). Our
study reported savings of approximately $1000 from an HCP perspective which is lower
than those reported in the US, but with overall lower associated procedure costs in
Canada and shorter hospital stays in both groups (14.9hrs versus 24.6hrs and 35.1hrs
versus 73.8hrs for the outpatient and inpatient groups respectively in this study and the
study conducted by Aynardi et al. (3) for example), this is to be expected. We also
investigated cost savings from a societal perspective, incorporating indirect costs for both
patients and their caregivers as an increasing number of patients are undergoing THA at a
younger age and are thus still in the workforce, and an important component of the
outpatient pathway involves caregiver support in the immediate post-surgery period. This
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resulted in approximately $2,700 in cost savings for outpatient THA when all indirect
costs were included.

There was uncertainty in our estimate of cost for the base case analyses as shown by the
wide 95% CIs spanning values over an almost $2,300 range for the HCP perspective and
approximately $4,000 range for the societal perspective, both of which included positive
values. ICERs calculated from these positive values would indicate that outpatient THA
is no longer dominant and is instead both more costly and more effective compared to
inpatient THA.

For the HCP perspective, the removal of two outliers greatly improved our uncertainty,
reducing the range of the 95% CI to approximately $400 and no longer including a
positive difference. When investigating these outliers further, it was found that both
participants had experienced adverse events which resulted in further treatment. One of
these participants experienced a deep infection which required surgical treatment via
irrigation and debridement, while the other participant required a revision THA procedure
after experiencing an intraoperative periprosthetic fracture. The inclusion of these two
participants in our base case analysis greatly increased the uncertainty in our estimate as
their costs were more than double that of the next largest reported cost over the study
period and both belonged to the inpatient group.

The results of our net benefit regression analysis demonstrate that when decision-makers
are willing to pay at least $500 for a one-point improvement in the total WOMAC score
from a societal perspective, or any amount from a healthcare payer perspective, outpatient
THA is cost-effective. Sensitivity analyses including further indirect costs for the societal
perspective and investigating patients who crossed over as treated showed our results to
be quite robust as our results compared to the base case did not alter greatly and
outpatient THA remained cost-effective at quite low WTP values for all scenarios. While
Canada does not currently have an accepted WTP threshold that is applied for new and
current treatments, a widely used WTP threshold is approximately $50,000 per qualityadjusted life year gained. While we were unable to evaluate quality-adjusted life years, as
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our study period did not cover a full year, our low WTP thresholds for cost-effectiveness
suggest that decision-makers may be accepting of this small additional cost for
improvements for patients.

As reported by Quintana et al. in 2005, the MCID in WOMAC scores within patients
undergoing THA is at least 25 points for each subscale (28). Goldsmith et al. proposed
that the between group MCID is approximately 20-40% of the within group MCID (29),
which would make a difference of at least five points applicable for the WOMAC
subscales. According to this standard, the difference we found between the groups in the
WOMAC function subscale of 7.0 points is clinically important, however the lower
bound of the 95% CI also includes non-clinically important differences of less than five.
The difference we found between groups for the total WOMAC score falls below the
threshold of five, as does both the upper and lower bounds of the 95% CI, therefore we
cannot say that the difference we found is clinically important to patients.

We found outpatients to spend significantly less time in hospital between admission and
surgery compared to inpatients, however this difference may be explained by the timing
of surgery. While 41 of 49 participants in the outpatient group had surgery before 9:00am,
only 11 of 56 participants in the inpatient group were within the same timeframe. Since
patients at our institution are requested to arrive three hours prior to surgery for all
surgeries occurring after 9:00am, but only two hours in advance of earlier surgeries, this
may explain the difference we found.

Our overall adverse event rate for the study was 9.5%. Rates of serious adverse events
range in the literature from as low as 3.8% up to 8.6% (30-33). Our overall serious
adverse event rate of 3.8% falls in the low end of this range.

A strength of this study is the blinding we were able to implement in our study design.
The modified Zelen consent model (21) allowed us to keep participants blinded to the
randomization process so that they were not aware of the presence of another study
group. We believe this helped us to limit our rate of cross-over compared to what Goyal
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et al. (2017) experienced in their study (20). Their cross-over rate was fairly high as their
participants were aware of the other group and had the option to switch due to personal
preference. Blinding is difficult in a study that looks to examine timing of discharge and
is not possible with most traditional study designs. While we also experienced cross-over
in the inpatient group, our overall rate was only 11% compared to 25% in Goyal et al.’s
study (20).

Another strength of our study is that it is the first study to include a full economic
evaluation alongside a prospective trial to assess outpatient THA. Previous studies that
have evaluated cost of outpatient THA have been retrospective, generally with national
databases. This is also the first study to include indirect costs when exploring outpatient
THA. The inclusion of indirect costs in a societal perspective is important, especially
when evaluating outpatient THA, as an argument against early discharge could be made
for the reallocation of costs from the hospital stay to further care from friends or family,
or to unplanned returns to clinic or emergency rooms. By including these costs in our
analyses, we have shown this not to be the case. It’s also important when conducting an
economic evaluation to include multiple perspectives to ensure generalizability of study
results. The inclusion of multiple perspectives is recommended by international health
economic guidelines (34) and its importance was demonstrated by Primeau et al. (2019)
when they showed that conclusions of a study can change dependent on which costing
perspective is used (35).

This study is a preliminary analysis of the first group of patients to complete follow-up of
a larger randomized trial. As such, a limitation of this study is the relatively small sample
size. A larger sample size is required to have sufficient power to determine the true costeffectiveness and safety of outpatient THA. A larger sample will also help to reduce the
uncertainty in our estimates and provide more precision in our results as the ranges in
both cost and effect are quite large.
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2.7 Conclusions
Our study found outpatient THA to be cost-effective compared to inpatient THA at all
WTP values for the healthcare payer perspective and at WTP values of $500 or greater
for the societal perspective. Outpatient THA had lower costs from both HCP and societal
perspectives, and higher total WOMAC scores at 12 weeks post-surgery when compared
with inpatient THA, though confidence intervals around the estimates were large. We also
found similar adverse event rates between the two groups. While a larger sample size is
needed to provide more precision around our estimates, this is the first study to use a
blinded randomization model to examine the cost-effectiveness of outpatient THA.
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Chapter 3: Assessment of informal caregiver assistance and strain
with total hip and knee arthroplasty

3.1 Abstract
Background
Total hip and knee arthroplasty (THA and TKA) are successful procedures for the
treatment of severe hip and knee osteoarthritis. While the impact of THA and TKA
procedures on patients has been widely studied, little research has been conducted to
assess how these procedures affect the informal caregivers of these patients. The aim of
our study was to assess which patient- and caregiver-related factors are predictive of
caregiver strain and assistance when caring for THA and TKA patients within the first
two weeks after surgery.

Methods
We conducted a prospective cohort study of caregivers of participants enrolled in two
randomized trials. Caregivers completed a demographics form at the first visit and two
self-reported questionnaires, the Caregiver Strain Index (CSI) and the Caregiver
Assistance Scale (CAS) pre- and post-surgery. We performed backwards stepwise
regression with a mixed-effects negative binomial model to investigate which predictors
are significantly related with caregiver strain and assistance.

Results
Three hundred and six caregiver/patient pairs were included in our analysis. Our model of
caregiver strain found CAS scores (IRR 1.03, 95% 1.02, 1.03) to be a positive predictor
of strain and female patient sex (IRR 0.74, 95% CI 0.57, 0.96) and caregiver age (IRR
0.77, 95% CI 0.68, 0.88) to be negative predictors of strain. Our model of caregiver
assistance found length of stay (IRR 1.12, 95% CI 1.01, 1.24) to be a positive predictor of
assistance and time (pre-surgery compared to post-surgery) (IRR 0.47, 95% CI 0.42,
0.54) and female patient and caregiver sex (IRR 0.58, 95% CI 0.43, 0.79 and IRR 0.56,
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95% CI 0.41, 0.77 respectively) to be negative predictors of the amount of assistance
provided by caregivers.

Conclusions
Our study identifies patient- and caregiver-related factors which are associated with
caregiver strain and assistance when caring for THA and TKA. As this is the first study to
assess the amount of assistance provided by caregivers, it’s important for future research
to validate our results and to further explore whether patient-reported outcomes may also
be related to assistance and strain. Our study may also contribute to a greater
understanding of differing educational and at home supports required by patients with
different presenting characteristics.
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3.2 Introduction
Total hip and knee arthroplasty (THA and TKA) are highly successful procedures for the
treatment of severe hip and knee osteoarthritis. While the impact of THA and TKA
procedures on patients has been widely studied, little research has been conducted on the
informal caregivers of these patients. With the increased emphasis on enhanced recovery
care pathways and shorter length of stay in hospital after total joint replacements, it’s
especially important to assess the impact on caregivers as more responsibility is being put
onto them earlier in the recovery pathway. Care activities normally done by healthcare
professionals in the hospital may now need to be performed by patients and their
caregivers at home.

To better understand the impact of joint replacement procedures on the caregivers of
these patients, it’s necessary to include the caregivers in the research process. A previous
study at our institution by Churchill et al. (2018) qualitatively assessed the impact of
outpatient discharge on patient and caregivers after THA (1). They found patients
reported caregiver support to be essential to their recovery and supporting their transition
home. These patients also described the assistance provided by their caregivers as
extensive in regard to self-care and mobility (1).

No research, as of yet, has quantitatively assessed the amount of assistance being
provided by caregivers of THA and TKA patients prior to surgery or in the early
postoperative period or how the amount of assistance provided may relate to caregiver
strain. However, one previous study by Zadzilka et al. (2018) quantitatively assessed
caregiver strain after TKA (2). They reported that patient and caregiver sex, race and
employment status, caregiver age and education level, patient knee-related quality of life
and both patient and caregiver mental component scores from the Veterans RAND 12
Item Health Survey (VR-12) were significantly correlated with caregiver strain four
weeks after surgery (2).

As recovery after THA and TKA procedures occurs rather rapidly in the early
postoperative phase, it is important to assess caregiver strain and assistance earlier than
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four weeks after surgery. The aim of our study was to assess which patient and caregiver
related factors are predictive of caregiver strain and amount of assistance when caring for
THA and TKA patients within the first two weeks after surgery.

3.3 Materials and Methods
We conducted a prospective cohort study to assess the strain and assistance provided by
caregivers of participants enrolled in two randomized trials. Both studies were assessing
cost and patient satisfaction associated with total joint arthroplasty. One study compared
total hip arthroplasty (THA) patients discharged as outpatients, on the same day as their
surgery, to those discharged as inpatients, overnight stay in hospital. The other study
compared total knee arthroplasty (TKA) patients who underwent surgery through two
different surgical approaches (medial parapatellar and midvastus), with or without a
tourniquet. Caregivers and patients were enrolled between June 2015 and March 2020.
The studies were conducted at a single centre and were approved by our institution’s
Research Ethics Board.

3.3.1

Selection Criteria

All patients who participated in the trials were asked if they had a caregiver and if they
were willing to have them approached for participation in this study. Caregivers were
excluded from participation if the patient could not identify a main caregiver who would
assist them postoperatively (i.e. had multiple caregivers), the associated patient was
withdrawn from the main trial, the caregiver declined to participate, or the caregiver was
unavailable at either opportunity for the initial visit. Caregivers were asked to participate
when they accompanied a patient to a hospital visit, either at the preadmission visit (less
than three months prior to surgery), or while in hospital at the time of surgery.

3.3.2

Outcome Assessment

Assessments were completed prior to or on the day of surgery and at two weeks
postoperatively for all caregivers. Caregivers completed a demographics form at the first
visit and two self-reported questionnaires, the Caregiver Strain Index (CSI) and the
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Caregiver Assistance Scale (CAS) at each time point. The CSI is a 13-item dichotomous
(yes/no) questionnaire designed to assess perceived informal caregiver burden when
providing care for a patient (3). The questionnaire is scored from 0 to 13 with scores
greater than, or equal to, seven indicating high strain. The CAS is a 17-item questionnaire
designed to assess the amount of assistance provided by the caregiver (4). The
questionnaire assesses three groups of activities including activities of daily living (i.e.
bathing, eating), instrumental activities of daily living (i.e. finances), and treatment
related activities (i.e. administration of medications). Each question is scored on a sevenpoint Likert scale from zero (none) to six (a lot). To calculate the CAS score, the scores
for each question were summed for a total score between 0 and 119.

3.3.3

Statistical Analysis

Data analysis was completed using Stata version 16.1 software (StataCorp 2019). We
used descriptive statistics to present the demographic characteristics of the caregivers and
patients with proportions for nominal variables (relationship between the caregiver and
patient, sex, smoking status, education level, employment status, operative joint) and
means and standard deviations for continuous variables (age, body mass index [BMI]).
Overall scores for the CSI and CAS at each time point for caregivers of THA and TKA
patients were presented separately with means and standard deviations.

We performed backwards stepwise regression with a mixed-effects negative binomial
model to investigate which predictors are significantly related with i) caregiver strain
(total score on the CSI) and ii) amount of assistance (total score on the CAS). A mixedeffects model was used to account for the questionnaires being collected at two time
points from the same participants. All participants were included in the models as mixed
effects models are able to accommodate missing data. Independent variables included in
our models included: time (pre- and post-surgery), operative joint (hip or knee), length of
stay (days), complications within the first two weeks post-surgery (yes or no),
relationship (spouse, family, non-family), patient demographic factors (age, sex, Charlson
Comorbidity Index [CCI] score, employment status [working or not], education level
[high school education or less, some or graduated from college, postgraduate school or
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degree], smoking status [yes or no] and BMI) and caregiver demographic factors (age,
sex, employment status [working or not], education level [high school education or less,
some or graduated from college, postgraduate school or degree], smoking status [yes or
no] and BMI). Random intercepts and slopes were specified by participant ID and time
terms. We removed independent variables from the model with p > 0.20 and then
presented the incident rate ratios (IRR) with 95% confidence intervals for each remaining
predictor.

An additional analysis was planned to examine predictors of high strain in caregivers by
dichotomizing the CSI scores ( 7 as high strain, < 7 as low strain). We then performed
backwards stepwise regression with a logistic mixed effects model and presented odds
ratios (OR) with 95% confidence intervals.

3.4 Source of Funding
The randomized hip study was supported by the Opportunities Fund of the Academic
Health Sciences Centre Alternative Funding Plan of the Academic Medical Organization
of Southwestern Ontario (AMOSO) and was funded by a grant from Physicians’ Services
Incorporated (PSI) Foundation. The randomized knee study was funded by Stryker
Canada.

3.5 Results
A total of 353 patient/caregiver pairs were enrolled in our study (Figure 3-1) and 306
pairs were included in our analysis for an overall recruitment rate of 54%. Five
participant/caregiver pairs participated in both the hip and knee randomized trials. These
pairs were removed from the second study in which they had participated to ensure they
were not duplicated in the analysis. There was also one instance where a
participant/caregiver pair participated in both studies however the participant in one study
was the caregiver in the other and vice versa (i.e. the wife was the participant in the hip
study and the husband was the participant in the knee study). This participant/caregiver
pair was retained in the analysis.
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Figure 3-1. CONSORT diagram of participant flow through the study.
Demographics for the patients are summarized in Table 3-1 and for the caregivers in
Table 3-2. While patients were evenly split between males and females, caregivers were
predominantly female. The majority of caregivers were spouses of the patients. TKA
patients were older, less likely to be employed, less educated, had higher BMIs, remained
longer in hospital and experienced more complications than THA patients. Similarly,
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caregivers of TKA patients were also older, less educated and less likely to be employed
compared to caregivers of THA patients.
Table 3-1. Patient Demographics.
Characteristic

Combined
(n=306)
28.4  5.0
64.2  9.7
154 (50.3)
29 (9.5)

Hip
(n=247)
27.7  4.9
63.4  10.1
125 (50.6)
24 (9.7)

BMI  SD, kg/m2
Age  SD, year
Sex (Male), n (%)
Smokers, n (%)
Education, n (%)
Highschool or less
86 (33.2)
61 (30.5)
College
120 (46.3)
95 (47.5)
Postgraduate School or Degree
53 (20.5)
44 (22.0)
Employment Status (Yes), n (%)
135 (44.1) 118 (47.8)
Charlson Comorbidity Index  SD 0.4  0.7
0.4  0.7
Length of Stay (Days)  SD
0.8  0.9
0.7  0.8
Complications (Yes), n (%)
32 (10.5)
21 (8.5)
Abbreviations. BMI = body mass index, SD = standard deviation.

Knee
(n=59)
31.2  4.4
67.4  7.2
29 (49.2)
5 (8.5)
25 (42.4)
25 (42.4)
9 (15.3)
17 (28.8)
0.4  0.7
1.7  0.8
11 (18.6)

Table 3-2. Caregiver Demographics.
Characteristic

Combined
(n=306)
27.2  5.3
61.0  12.2
115 (37.6)
31 (11.4)

Hip
(n=247)
27.2  12.6
60.1  5.4
93 (37.7)
23 (10.8)

BMI  SD, kg/m2
Age  SD, year
Sex (Male), n (%)
Smokers, n (%)
Education, n (%)
Highschool or less
75 (27.0)
54 (24.6)
College
135 (48.6)
108 (49.1)
Postgraduate School or Degree
68 (24.5)
58 (26.4)
Employment Status (Yes), n (%)
143 (51.3)
122 (55.5)
Relationship, n (%)
Spouse
253 (82.7)
207 (83.8)
Family
41 (13.4)
33 (13.4)
Non-Family
12 (3.9)
7 (2.8)
Abbreviations. BMI = body mass index, SD = standard deviation.

Knee
(n=59)
27.1  4.8
64.1  10.1
22 (37.3)
8 (13.8)
21 (36.2)
27 (46.6)
10 (17.2)
21 (35.6)
46 (78.0)
8 (13.6)
5 (8.5)
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Overall caregiver strain as assessed by the CSI was low both pre- and post-surgery,
though strain did increase from pre- to post-surgery (Table 3-3). The amount of assistance
provided by caregivers increased from pre- to post-surgery but remained low at both time
points.

Table 3-3. CSI and CAS scores at baseline and two weeks post-surgery.
Questionnaire

Time Point

Combined
Hip
Knee
(n=306)
(n=247)
(n=59)
CSI
Preop
1.5  2.3
1.7  2.4
1.0  1.5
2 Weeks
2.5  2.8
2.6  3.0
2.2  2.2
CAS
Preop
15.8  16.7
15.1  15.6
18.5  20.6
2 Weeks
27.9  17.2
27.2  16.4
30.9  19.9
Abbreviations. CSI = Caregiver Strain Index, CAS = Caregiver Assistance Scale.

Four percent of caregivers experienced high strain while caring for patients prior to
surgery which increased to 11% at two weeks post-surgery (Table 3-4).

Table 3-4. Number of caregivers who indicated high strain on the Caregiver Strain Index
indicated as a score greater than or equal to seven.
Time Point
Preop
2 Weeks

Combined
(n=306)
10 (4.3)
26 (11.4)

Hip
(n=247)
10 (5.6)
23 (13.2)

Knee
(n=59)
0
3 (5.5)

Our model of caregiver strain found CAS scores, patient sex and caregiver age to be
significant predictors of strain (Table 3-5). Caregiver strain increased by three percent
(IRR 1.03, 95% 1.02, 1.03) for each point increase on the CAS. CSI scores were on
average 26% (IRR 0.74, 95% CI 0.57, 0.96) lower for caregivers of female patients
versus caregivers of male patients and CSI scores decreased by 23% (IRR 0.77, 95% CI
0.68, 0.88) for every 10-year increase in caregiver age.
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Table 3-5. Negative binomial mixed effects model estimates for caregiver strain.
Fixed Effects
Variable
IRR
Standard Error 95% CI
Time
Post-Surgery
Reference
Pre-Surgery
0.84
0.09
0.68 to 1.02
CAS
1.03
<0.01
1.02 to 1.03
Patient Sex
Male
Reference
Female
0.74
0.10
0.57 to 0.96
Patient Smoking Status
No
Reference
Yes
0.69
0.18
0.42 to 1.13
Caregiver Age
0.77
0.05
0.68 to 0.88
Caregiver Employment
Yes
Reference
No
0.78
0.12
0.58 to 1.05
Caregiver Smoking Status
No
Reference
Yes
0.76
0.16
0.50 to 1.16
Intercept
5.13
1.95
2.44 to 10.80
Random Effects
Variable
Variance
Standard Error 95% CI
Intercept
0.34
0.12
0.18 to 0.66
Abbreviations. IRR = incident rate ratio, CI = confidence interval, CAS = Caregiver
Assistance Scale.

Our model of caregiver assistance found time (pre- versus post-surgery), length of stay,
patient sex and caregiver sex to be significant predictors of the amount of assistance
provided by caregivers (Table 3-6). Caregiver assistance was 53% lower (IRR 0.47, 95%
CI 0.42, 0.54) pre-surgery compared to post-surgery. For each day increase in length of
stay in hospital, caregiver assistance increased on average 12% (IRR 1.12, 95% CI 1.01,
1.24). Caregiver assistance was on average 42% (IRR 0.58, 95% CI 0.43, 0.79) lower for
caregivers of female patients compared to male patients and 44% (IRR 0.56, 95% CI
0.41, 0.77) lower for female caregivers compared to male caregivers.
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Table 3-6. Negative binomial mixed effects model estimates for caregiver assistance.
Fixed Effects
Variable
IRR
Standard Error 95% CI
Time
Post-Surgery
Reference
Pre-Surgery
0.47
0.03
0.42 to 0.54
Length of Stay
1.12
0.06
1.01 to 1.24
Patient BMI
1.07
0.05
0.97 to 1.18
Patient Sex
Male
Reference
Female
0.58
0.09
0.43 to 0.79
Patient Employment
Yes
Reference
No
1.17
0.12
0.95 to 1.43
Caregiver Age
0.94
0.04
0.86 to 1.02
Caregiver Sex
Male
Reference
Female
0.56
0.09
0.41 to 0.77
Intercept
42.29
20.86
16.08 to 111.20
Random Effects
Variable
Variance
Standard Error 95% CI
Intercept
0.28
0.06
0.19 to 0.42
Abbreviations. IRR = incident rate ratio, CI = confidence interval, BMI = body mass
index.

Our model of high strain found CAS scores, operative joint and patient age to be
significant predictors of high versus low caregiver strain measured as a score equal to or
greater than seven on the CSI (Table 3-7). The odds of a caregiver experiencing high
strain increased by nine percent (OR 1.09, 95% CI 1.03, 1.15) for every point increase on
the CAS and decreased by 56% (OR 0.45, 95% CI 0.21, 0.97) for every 10-year increase
in patient age. Caregivers of TKA patients were 94% less likely (OR 0.06, 95% CI 0.01,
0.80) to experience high strain compared to those caring for THA patients.
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Table 3-7. Logistic mixed effects model estimates for high versus low caregiver strain.
Fixed Effects
Variable
Odds Ratio Standard Error 95% CI
Time
Post-Surgery
Reference
Pre-Surgery
0.53
0.31
0.17 to 1.68
CAS
1.09
0.03
1.03 to 1.15
Operative Joint
Hip
Reference
Knee
0.06
0.08
0.01 to 0.80
Relationship
Spouse
Reference
Family
7.60
8.05
0.95 to 60.66
Non-Family
5.32
8.00
0.28 to 101.43
Patient Age
0.45
0.18
0.21 to 0.97
Patient Sex
Male
Reference
Female
0.24
0.19
0.05 to 1.14
Patient Employment
Yes
Reference
No
3.11
2.52
0.63 to 15.28
Intercept
0.30
0.63
<0.01 to 17.94
Random Effects
Variable
Variance
Standard Error 95% CI
Intercept
3.86
4.34
0.43 to 34.97
Abbreviations. CI = confidence interval, CAS = Caregiver Assistance Scale.

3.6 Discussion
The purpose of our study was to identify patient- and caregiver-related factors which may
be predictive of caregiver strain and assistance when caring for hip and knee arthroplasty
patients. We found the amount of assistance provided to be a positive predictor of
caregiver strain and female patient sex and caregiver age to be negatively predictive of
caregiver strain. We also found length of stay in hospital to be a positive predictor of
caregiver assistance and time (pre- versus post-surgery), female patient and caregiver sex
to be negative predictors of caregiver assistance.
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Demographics of our caregivers were largely similar to previous studies of caregivers of
arthroplasty patients with the vast majority of caregivers being spouses of the patients (5–
7) and female (5–8) and approximately half being employed (2,7–9). The average age of
our caregivers was also similar to previous studies with an average age of 61 years
(2,5,9).

The average CSI scores we reported in our study were lower than those reported by other
studies in the literature. A study by Zadzilka et al. (2018), is the only currently published
study which used the CSI to assess strain in caregivers of arthroplasty patients (2). Their
reported scores were slightly higher than those we found both prior to (2.24 versus 1.5
respectively) and early after surgery (3.32 versus 2.5 respectively), though they measured
post-surgery strain later at four weeks after surgery and only looked at caregivers of TKA
patients (2). As would be expected, the average CSI scores found in our study were lower
than those reported in caregivers of patients undergoing abdominal surgery (10) and much
lower than those caring for elderly dependent people (11). We also reported a lower
proportion of caregivers experiencing high strain, considered as a score on the CSI greater
than or equal to seven, than caregivers of hip fracture patients, only 11% at two weeks
post-surgery in our study compared to 50% at one-month post-surgery (12).

Similar to previous studies, we found caregiver age to be a significant predictor of
caregiver strain (2,12). While Zadzilka et al. (2018) found a similar relationship where
strain decreases with increasing caregiver age (2), a study by Ariza-Vega et al. (2019)
found the opposite with increased odds of experiencing high strain as age increases (12).
The opposing results may be explained in the demographic differences between the
studies as patients in this study had an average age of 80 years (12), while our study had
an average age of 64 years and the study by Zadzilka et al. had an average age 66 years
(2). The study by Ariza-Vega et al. was also investigating strain in a population caring for
hip fracture patients as opposed to elective arthroplasty patients which may not be
comparable as the population of patients experiencing hip fractures tend to be more frail
and thus may require more assistance from their caregivers (12).
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We also found patient sex to be predictive of caregiver strain with caregivers of female
patients experiencing significantly less strain than those caring for male patients. Like
with our study, Casado-Mejía et al. (2016) also found that caregivers of female patients
experienced less strain than those caring for male patients (11). They suggest the reason
for this discrepancy between the sexes may not be due to less need for care in women, but
instead women not asking for help as readily as men (11). In our study, patient sex was
also found to be significantly predictive of the amount of assistance provided by
caregivers with those caring for female patients providing less assistance. It’s possible
that caregivers are not asked to provide as much assistance to female patients and thus do
not experience as much strain as those providing more care. However, this cannot be
definitively concluded from our results as it’s also possible that female patients simply
required less assistance. Future research could explore this further.

Surprisingly, we did not find patients experiencing a complication to be a significant
predictor of caregiver strain after hip or knee arthroplasty. It’s possible that this is due to
the low number of complications experienced by the patients in the study as only 10.5%
experienced a complication within the first two weeks after surgery. Our finding is also
not surprising as a majority of the reported complications were relatively minor and did
not affect functional ability (e.g. haematoma, stitch abscess, superficial infection). We
also did not find comorbid status, as measured with the CCI, to be predictive of caregiver
strain. As our patient population was fairly homogenous in regard to CCI score, with the
majority of patients (90%) scoring zero or one, it’s unsurprising that we did not find a
relationship. The study by Janssen et al. (2020) reported that caregivers of patients with
higher comorbidity experienced higher strain, though the median CCI score in their
population was six (10). It’s possible that with a more diverse and comorbid population,
we may have also found comorbid status to be predictive of caregiver strain though this
was beyond the scope of the study.

The CAS was developed in an advanced cancer population (4) and has yet to be used to
assess the amount of assistance being provided by caregivers of arthroplasty patients. We
thought it would be important to not only assess the strain that caregivers are
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experiencing when caring for these patients, but also to assess the amount of assistance
being provided as length of stay in hospital is being shortened and more responsibility is
being placed on these caregivers earlier in the recovery pathway. Using this tool, we were
able to determine that caregivers who provide more support both before and after surgery
experienced higher levels of strain and that they were at greater odds of experiencing high
strain. We also found that length of stay is predictive of the amount of assistance provided
by caregivers, however the relationship was opposite to what we had hypothesized.
Increasing length of stay was determined to increase the amount of assistance being
provided by caregivers. It’s possible that patients who remain in hospital longer are not
doing as well as patients who are discharged earlier. As would be expected, we also found
caregivers to provide significantly more care post-surgery compared to pre-surgery.
Considering the population of patients included in our study, this intuitively makes sense
as all patients were relatively healthy and independent prior to surgery.

A strength of this study is the large number of participants included. While previous
studies which have investigated caregiver strain have also included large numbers of
patients, this is the largest study to quantitatively assess caregivers of joint arthroplasty
patients. This is also the first study to assess the amount of care being provided by
caregivers of arthroplasty patients and to assess caregiver strain so early post-surgery.
The only previous quantitative study evaluated burden after TKA at four weeks postsurgery (2) while we used a two-week time point. As the majority of caregiving activities
are likely required immediately post-surgery, including early time points is important to
gaining a clear picture of how much strain caregivers experience.

There are several limitations of our study as well. A criticism of stepwise regression is the
risk of overfitting the model, and though we made choices to reduce the likelihood of this,
it’s possible that our models are more complex than our data allows. Our secondary
analysis of high versus low caregiver strain was underpowered due to the low number of
caregivers who experienced high strain (n=36). Since this is one of the first studies to
assess this outcome in an arthroplasty population, we felt it appropriate to evaluate all
predictors to get a sense of which predictors are likely to be important and encourage
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others to further validate our model in a larger sample with an appropriate number of
caregivers who experienced high strain. Another limitation is the short time frame of the
study, with caregivers only completing questionnaires pre-surgery and at two weeks postsurgery. It may be helpful to include measures of caregiver strain and assistance at
multiple further time points to better elucidate the trajectory of caregiver assistance and to
determine when and if patients no longer require assistance after joint arthroplasty.
Finally, our overall enrollment rate was relatively low at only 54%, however this is in line
with previous studies of caregivers of arthroplasty patients with enrollment rates ranging
from approximately 35-60% (2,5–8).

3.7 Conclusions
Our study found that caregivers who provide more assistance experience greater strain,
and that older caregivers and those caring for female patients experience less strain. We
also found caregivers to provide more assistance post-surgery compared to pre-surgery
and that the amount of assistance provided increases with increasing length of stay in
hospital. Female caregivers and caregivers of female patients were also found to provide
less assistance than if patients or caregivers were male. Future research should validate
our findings in a larger sample and investigate whether patient-reported outcomes both
before and after surgery are related to caregiver strain and assistance.
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Chapter 4: Trajectory of early functional recovery after total knee
arthroplasty compared between the medial parapatellar and
midvastus surgical approaches

4.1 Abstract
Background
Many surgical approaches have been adopted over the years in the hopes of improving
postoperative outcomes and reducing length of stay in hospital for total knee arthroplasty
(TKA). Two such approaches include the medial parapatellar (standard) and midvastus.
As the midvastus approach does not disrupt the extensor mechanism, it may be
advantageous for functional recovery in the early postoperative period which could
translate to shorter length of stay in hospital, faster rehabilitation and achievement of
functional milestones. The purpose of this study was to inform the surgical protocol of a
future large randomized trial to assess the cost-effectiveness of outpatient TKA by
comparing the trajectory of early functional recovery after TKA between the standard and
midvastus surgical approaches.

Methods
We conducted a 2x2 factorial randomized trial for patients undergoing primary TKA.
Participants were randomized to either have the standard or midvastus surgical approach
used during surgery, with or without the use of a tourniquet. Participants completed the
Timed Up and Go (TUG) test, strength testing and a self-reported pain questionnaire
before surgery and at discharge, two-, six- and 12-weeks post-surgery. Pain was also
measured daily for the first two weeks post-surgery. Instrumented sensors were worn
during the TUG to collect additional spatiotemporal gait data. Analyses were completed
at the margins to assess the effect of surgical approach on the trajectory of recovery using
mixed effects growth curve models with tourniquet use, baseline values, age, sex, body
mass index and previous TKA experience included as covariates.
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Results
Eighty-four participants were included in our analyses. Our models found significant
group by time interactions for pain within the first two weeks after surgery (-0.97 points
[95% CI -1.81, -0.13]) and stride length (Chi2[3]=9.40, p=0.02). All other outcomes
displayed similar trajectories of recovery for each surgical approach group (p>0.05).

Conclusions
Our study found the midvastus surgical approach to provide some small advantages in the
early recovery period for pain recovery within the first two weeks after surgery and
recovery of stride length. The majority of functional outcomes measured, however did not
have a significant group by time interaction effect. As neither approach was found to
provide a significant advantage for most functional outcomes measured, either surgical
approach would be appropriate for use in a future randomized trial investigating the
safety and cost-effectiveness of outpatient TKA.
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4.2 Introduction
Total knee arthroplasty (TKA) is a successful procedure for the treatment of severe knee
osteoarthritis, however a significant portion of patients are dissatisfied with the outcome
of their surgery (1). Many surgical approaches have been adopted over the years in the
hopes of improving postoperative outcomes and reducing length of stay in hospital. Two
such approaches include the medial parapatellar and midvastus. The medial parapatellar
surgical approach is a common approach familiar to most surgeons and provides excellent
exposure of the knee joint, but disrupts the extensor mechanism (2). The midvastus
surgical approach is similar to the medial parapatellar approach, but spares the majority of
the insertion of the vastus medialis on the quadriceps tendon (2). As disruption of the
quadriceps tendon is avoided with the midvastus surgical approach, it’s proposed that this
may allow for accelerated rehabilitation and shorter hospital stay, however this has not
been definitively borne out in the existing literature (3–6).

Previous meta-analyses have reported decreased pain and improved range of motion
within the first two weeks after surgery for the midvastus surgical approach in
comparison to the medial parapatellar (3–5), however the midvastus approach is also
associated with longer operative time (3–6). Similar results between the surgical
approaches were found when evaluating pain and function up to two years after surgery
(4,6).

Few studies have compared gait outcomes between these two approaches and report
conflicting results (7–9). A randomized trial conducted by Nutton et al. in 2014
compared, among other outcomes, knee extensor strength, the Timed Up and Go (TUG)
test and walking speed and found no clinically or statistically significant differences
between the groups (7). Satterly et al. (2013) compared two additional surgical
approaches in their randomized trial, including the standard and mini-parapatellar, minimidvastus and mini-subvastus and reported that no one surgical approach outperformed
any other up to six months post-surgery (8). Pethes et al. (2014), in contrast, reported
faster recovery towards normal values for the midvastus approach in comparison to the
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medial parapatellar approach for all gait outcomes they measured at six- and 12-weeks
including cadence, knee motion and pelvic and shoulder tilt and rotation (9).

Gait analysis is a sensitive and comprehensive method to investigate differences in
recovery of functional mobility after TKA. To date, no published studies have used gait
analysis earlier than six weeks after surgery to compare functional recovery between the
medial parapatellar and midvastus surgical approaches. Early gait outcomes could be
affected by the greater disruption of extensor mechanism as caused by the medial
parapatellar approach. The midvastus approach may be advantageous for functional
recovery in the early postoperative period as the extensor mechanism is left intact, which
could translate to shorter length of stay in hospital, faster rehabilitation and achievement
of functional milestones in the recovery of independent mobility.

The purpose of this randomized trial was to inform the surgical protocol of a future large
randomized trial to assess the safety and cost-effectiveness of outpatient TKA. To achieve
this purpose, we compared the trajectory of functional recovery after TKA over the first
12-weeks after surgery between the medial parapatellar and midvastus surgical
approaches.

4.3 Materials and Methods
We conducted a randomized trial with a two-by-two factorial design to compare the
medial parapatellar surgical approach to the midvastus surgical approach for TKA with
and without the use of a tourniquet. All participants underwent surgery between August
2017 and February 2020. The study was conducted at a single centre among patients of
two fellowship trained arthroplasty surgeons and was approved by our institution’s
Research Ethics Board and registered at clinicaltrials.gov (NCT03081663). This chapter
presents the results of the comparison between the surgical approach groups.

4.3.1

Selection Criteria

We included patients requiring primary TKA who were willing and able to comply with
follow-up requirements and self-evaluations, and willing to sign an approved informed
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consent form. Inclusion criteria also included English fluency (as printed instructions
were provided in English only), varus knee alignment, osteoarthritis, American Society of
Anesthetists (ASA) score of three or less, access to a home or cell phone, and an adult to
accompany the patient home post-operatively and to stay with the patient for a minimum
period of one to two days.

We excluded patients who were diagnosed with inflammatory arthritis, had a body mass
index (BMI) greater than 40 or less than 18, were skeletally immature, had an active or
suspected latent infection in or about the joint, had bone stock inadequate for support or
fixation of the prosthesis, hardware precluding intramedullary instrumentation, prior
osteotomies of the femur or tibia, lived greater than 90 minutes from the hospital, were
without access to caregivers, or unable to go directly to their home after surgery,
cognitive or neuromotor conditions, significant pain management issues, or had a family
history of anaesthesia-related complications (e.g. malignant hypothermia,
pseudocholinesterase deficiency, airway difficulties, obstructive sleep apnea). We also
excluded patients who had significant psycho/social issues that would prevent the patient
from managing at home safely.

4.3.2

Randomization

Participants were enrolled at their preadmission visit to the hospital, up to three months
prior to their surgery, and were allocated to one of four treatment groups via a web-based
randomization system using block randomization. We stratified the randomization by
surgeon and previous experience with TKA (whether themselves, or a family member or
friend they helped care for after surgery). We randomly allocated patients in a 1:1:1:1
ratio to receive their knee replacement with either the medial parapatellar (standard) or
midvastus surgical approach as well as with or without a tourniquet. Both participants and
research staff were kept blinded to group allocation until the participants reached the final
study visit.
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4.3.3

Treatments

Both surgical approaches were completed using a straight midline incision. The medial
parapatellar arthrotomy was performed leaving five mm of tendon medially to enable
closure after the TKA was performed. The midvastus surgical approach was performed
by identifying the superior medial corner of the patella. Distally the arthrotomy was the
same as the medial parapatellar approach, skirting the patella and proceeding adjacent to
the patellar tendon to the tibia itself. Proximally, the approach extended proximally and
medially in line with the muscle fibers of the vastus medialis. An intramedullary femoral
guide and extramedullary tibial guide were utilized during surgery in the standard of care
group while computer assisted navigation was utilized for the midvastus group.
Navigation was used only for the midvastus approach as it has been implicated in
decreased accuracy of implant alignment. All other aspects of the surgery were kept the
same between the groups and all participants had a cemented Stryker Triathlon implant
used for their surgery.

4.3.4

Sample Size

As the main purpose of this study was to inform the surgical protocol of a future
randomized trial, we aimed to include 40 patients per year for a total of 80 participants.

4.3.5

Outcome Assessment

We completed assessments prior to surgery, at discharge from the hospital, and at two-,
six- and 12-weeks after surgery. We recorded adverse events at each study visit and
surgical characteristics such as change in haemoglobin, operative time, tourniquet time,
length of stay and type of anaesthesia.

4.3.5.1 Pain
Participants completed a Visual Analog Scale (VAS) for pain at all study visits, on an 11point scale from zero (no pain) to ten (worst pain imaginable). Pain was also assessed
daily for the first two weeks after surgery with a daily diary provided to participants on
the day of discharge from hospital using a 101-point VAS scale measured from zero (no
pain) to 100 (worst pain imaginable).
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4.3.5.2 Strength
Research staff measured participants motor power (quadriceps strength) via maximum
voluntary isometric contraction at all study visits with a handheld dynamometer (Manual
Muscle Tester, Lafayette Instrument Company). Participants were seated in a chair with
their knee bent at 90 degrees while the research staff placed the dynamometer on the
participant’s shin, just above the ankle. The participants were then asked to kick out with
their leg, attempting to straighten their knee, while the research team member applied
enough force to resist movement of the leg. Testing was repeated up to three times on
each leg as the participant was able and the average force generated over the trials was
used for analysis.

4.3.5.3 Timed Up and Go Test
Participant function was assessed using the TUG test. The TUG was administered at all
study visits and involved timing the participant as they stood up from a chair, walked
three metres at a comfortable pace, turned around and returned to a seated position. Up to
three trials were performed at each visit as the participants were able and the average time
over the trials was used for analysis.
During performance of the TUG, the LEGSysTM Plus system of sensors (BioSensics LLC
2015) were worn around the waist, each shin and each thigh. The sensors collected
spatiotemporal gait data including stride length (as a percentage of height), net speed
(computed as total walking distance divided by walking time) and single support
(percentage of the gait cycle when the foot is in contact with the ground). Single support
was collected for both the operative and non-operative legs. Once again, the average of
the trials was used for analysis.

4.3.6

Statistical Analysis

We completed our statistical analysis using Stata/IC version 16.1 (StataCorp LLC 2019)
software and followed the intention-to-treat principle for our primary analysis. We used
descriptive statistics to present the demographic and surgical characteristics of the groups
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using means with standard deviations for continuous variables (BMI, age, change in
haemoglobin, operative time, tourniquet time and length of stay) and proportions for
categorical variables (sex, contralateral knee symptoms, contralateral TKA, smoking
status, ASA score, Charlson Comorbidity Index and type of anaesthesia).

We evaluated the trajectory of pain, TUG, motor power and spatiotemporal gait outcomes
(single support time, stride length and net speed) over time using linear mixed effects
growth curve modelling (LME). All patients were included in the models as LME are
able to accommodate missing data. Models were built with time, surgical approach and
their interaction included as independent variables. We included tourniquet use (yes or
no), baseline values of each outcome, age (per 10 years), sex, BMI (per five units) and
previous experience with TKA (yes or no) as covariates in the model. Covariates were
added after the model was specified. Time, measured in weeks, was entered into the
model as a continuous variable with discharge from hospital indicated as week zero. We
also evaluated daily pain over the first two weeks after surgery with time measured in
days. Random intercepts and slopes were specified by participant ID and time terms. We
tested the assumptions of the LME including normality and homoskedasticity. Models
addressing nonlinearity and covariance structures were selected based on Baysian
Information Criterion (BIC) and likelihood ratio tests. We used Wald tests to investigate
group by time effects for each outcome and margins to predict outcome scores at weekly
time points. All participants were analyzed according to the intention-to-treat principle, in
the group to which they were assigned, regardless of whether they crossed over. We also
performed a sensitivity analysis by analyzing participants as treated. In addition, we
tested the assumption of the factorial design that there is no interaction effect between
surgical approach and tourniquet use by including the interaction term in our analyses.

4.4 Source of Funding
This study was supported by a grant from Stryker Canada.
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4.5 Results
Ninety-one patients consented to take part in the study with five participants withdrawn
prior to randomization (Figure 4-1); two were withdrawn by their surgeon as a cementless
implant was chosen, two were included incorrectly as they were found to have a BMI
greater than 40, and one participant had their surgery moved up before randomization
could occur. A total of 86 participants were randomized in the study: 40 to the standard
group and 46 to the midvastus group. One participant was screen-failed after
randomization in the midvastus group as it was discovered they had obstructive sleep
apnea. Two participants from the standard group requested to be withdrawn over the
course of the study, one prior to surgery and one at the two-week visit after surgery.
Overall, nine participants crossed over and had the other surgical approach used during
surgery. Due to restrictions that were placed on clinics and research staff beginning in
March 2020 for COVID-19, one six-week visit and six 12-week visits were missed after
surgery.
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Figure 4-1. CONSORT diagram of participant flow through the study.
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Baseline demographic characteristics are listed in Table 4-1. The standard group had a
lower proportion of participants with ASA scores of three and Charlson Comorbidity
Index scores of two or more. Surgical characteristics were similar between the groups
(Table 4-2). There were two outliers with length of stay greater than 140 hours, both of
whom belonged to the standard group. These participants were unable to pass
physiotherapy discharge criteria after surgery and remained in hospital awaiting a bed at a
rehabilitation facility. There was one participant, also in the standard group, who was
discharged as an outpatient on the same day as their procedure.

Table 4-1. Demographic Characteristics.
Characteristic

Standard
(n=39)
32.4  4.1
67.1  7.7
21 (54)
27 (69)
11 (28)
4 (10)

Midvastus
(n=45)
30.1  4.5
69.8  7.3
18 (40)
29 (64)
9 (20)
3 (7)

BMI  SD, kg/m2
Age  SD, y
Sex (Male), n (%)
Contralateral Knee Symptoms, n (%)
Contralateral TKA, n (%)
Smokers, n (%)
ASA Score, n (%)
1
1 (3)
0
2
17 (44)
17 (38)
3
21 (54)
28 (62)
Charlson Comorbidity Index, n (%)
0
25 (64)
29 (64)
1
11 (28)
7 (16)
2
3 (8)
8 (18)
3
0
1 (2)
Abbreviations. SD = standard deviation, BMI = body mass index, ASA = American
Society of Anesthetists
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Table 4-2. Surgical Characteristics.
Parameters

Standard
Midvastus
Mean Difference
Mean (SD)
Mean (SD)
(95% CI)
Change in Haemoglobin, mmHg
-23.6 (7.4)
-24.2 (7.1)
-0.6 (-3.8, 2.6)
Operative Time, min
54.6 (9.0)
58.2 (8.9)
3.6 (-0.3, 7.5)
Tourniquet Time, min
32.4 (24.8)
38.4 (25.3)
6.1 (-4.8, 17.0)
Length of Stay, hrs, median (IQR) 44.5 (26.0, 50.0) 44.0 (26.0, 48.0) -13.8 (-34.1, 6.6)
Anaesthesia, n (%)
Spinal
36 (92)
43 (96)
General
3 (8)
2 (4)
Abbreviations. SD = standard deviation, CI = confidence interval, IQR = interquartile
range.
At discharge from hospital, a total of 10 participants refused or were unable to complete
the TUG test due to pain, nausea or inability to pass physiotherapy discharge criteria. At
two weeks, three participants refused or were unable to complete the TUG, while of those
missed, two participants were still admitted at a rehabilitation facility and therefore did
not attend clinic. For the strength testing, most participants refused or were unable to
complete testing due to pain. There were also two occasions where we were unable to
perform strength testing due to technical problems with the dynamometer. At two weeks,
one participant was unable to bend their knee to the required 90 degrees due to stiffness,
and therefore was unable to complete the strength testing. At discharge there was also one
instance where a patient had contact precautions listed while in hospital, therefore no
strength testing occurred, and the TUG test was performed without the sensors.

4.5.1

Adverse Events

No serious adverse events related to the surgical procedures occurred during the study
period, however several participants reported minor complications (Table 3). The rate of
minor and medical complications was higher in the standard group with 14 events in 10
participants versus eight events in seven participants in the midvastus group though not
statistically significant (p=0.25).
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Table 4-3. Adverse events occurring over the study period for the midvastus and standard
surgical approach groups.
Adverse Event
Minor Complications

Stiffness
Superficial Infection
Significant Bruising
Increased Pain
Urinary Retention
Fall
Medical Complications Allergic Reaction
Cardiac Arrythmia/Bradycardia
Increased Nocturia
Sweating, Chills, SOB
Total
Abbreviations. SOB = shortness of breath.
4.5.2

Standard
3
1
1
1
1
2
0
4
1
0
14

Midvastus
0
0
1
3
0
1
2
0
0
1
8

Linear Mixed Effects Growth Curve Models

4.5.2.1 Interaction Between Surgical Approach and Tourniquet Use
We did not find a significant interaction between surgical approach and tourniquet use in
our primary outcomes of TUG time and pain (p=0.81 and p=0.56 respectively), thus an
analysis of surgical approach at the margins was appropriate.

4.5.2.2 Between Group Results
We found sufficient evidence to support a between group difference in the trajectory of
patient-reported pain over the first two weeks after surgery (mean group by time
interaction -0.97 points [95% CI -1.81, -0.13]) and stride length (Chi2[3]=9.40, p=0.02).
The standard group had a steeper slope for recovery of pain, with greater pain at
discharge compared to the midvastus group but had similar pain at two-weeks postsurgery. For stride length, the midvastus group had a steeper slope of recovery early in
the post-surgery period compared to the standard group but had similar stride length at the
end of the study at 12-weeks post-surgery. We did not find sufficient evidence to suggest
a between group difference in the time course for any of the other outcomes measured.
When participants were analyzed as treated, the between group difference for stride
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length was no longer significant (Chi2[3]=6.11, p=0.11). Results for the other outcomes
did not change.

4.5.2.3 Predictors
We found baseline scores to be significant predictors of all outcomes with the exception
of pain within the first two weeks after surgery (Table 4-4). For all outcomes, pain over
the entire study period, TUG time, motor power, net speed, stride length and single limb
support time, baseline scores were positively predictive with post-surgery scores
increasing per unit increase in pre-surgery scores. Post-surgery pain increased by 0.22
points (95% CI 0.05, 0.40) per point increase in baseline pain, TUG time increased by
0.45 sec (95% CI 0.28, 0.61) for each second increase in baseline TUG time, motor power
increased by 0.35 lb (95% CI 0.21, 0.48) in the operative leg and 0.57 lb (95% CI 0.44,
0.71) in the non-operative leg for every one-unit increase in baseline motor power, net
speed increased by 0.33 m/s (95% CI 0.19, 0.46) for each unit increase in baseline net
speed, stride length increased by 0.45 percent (95% CI 0.29, 0.61) for each percent
increase in baseline stride length, and finally single leg support time increased by 0.27
percent (95% CI 0.15, 0.39) in the operative leg and by 0.34 percent (95% CI 0.17, 0.51)
in the non-operative leg per percent increase in baseline single support time.

We found age to be a positive predictor of both TUG time and single support time on the
operative leg (Table 4-4). TUG time increased by 0.74 sec (95% CI 0.01, 1.47), and
single support time on the operative leg increased by 1.23 percent (95% CI 0.60, 1.86) for
each 10-year increase in age.

We found BMI to be a positive predictor of TUG time and a negative predictor of net
speed and stride length (Table 4-4). TUG time increased by 0.69 sec (95% CI 0.03, 1.35)
for each five-unit increase in BMI. Net speed decreased by 0.03 m/s (95% CI -0.04, 0.01) and stride length decreased by 1.30 percent (95% CI -2.55, -0.04) for each five-unit
increase in BMI.
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Female sex was a significant negative predictor of TUG time and motor power on the
both the operative and non-operative legs (Table 4-4). Females completed the TUG in a
shorter time (-1.18 sec [95% CI -2.21, -0.14]) and had significantly decreased motor
power on the operative and non-operative legs (-5.24 lb [95% CI -8.46, -2.02] and -7.02
lb [95% CI -10.83, -3.20] respectively) compared to males.

Previous experience with TKA was not found to have a significant relationship with any
outcome measured (Table 4-4). Tourniquet use was not found to have a significant impact
on the operative limb.
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Table 4-4. Linear mixed effects model fixed effects estimates for all outcome models.
Variable

Pain

TUG

Motor Power

Net Speed

Stride Length

Single Support

β (SE)

β (SE)

β (SE)

β (SE)

β (SE)

β (SE)

Entire Study

First 2 Weeks

Operative

Non-Operative

Operative

Non-Operative

Group

0.26 (0.46)

10.95 (5.17)

0.22 (5.61)

0.75 (2.94)

0.31 (1.90)

0.04 (0.02)

1.90 (2.37)

-0.03 (1.72)

-1.19 (1.45)

Time

-0.24 (0.03)

-1.26 (0.25)

-27.27 (3.04)

3.96 (0.80)

0.50 (0.14)

0.23 (0.03)

14.19 (1.87)

-1.74 (0.37)

-10.80 (0.91)

Time2

-

-

4.60 (0.60)

-0.19 (0.06)

-

-0.03 (0.01)

-2.02 (0.42)

0.10 (0.02)

1.70 (0.21)

Time3

-

-

-0.22 (0.03)

-

-

<0.01 (<0.01)

0.09 (0.02)

-

-0.08 (0.01)

-0.02 (0.05)

-0.98 (0.43)

-0.35 (3.86)

-0.84 (1.05)

-0.12 (0.23)

-0.03 (0.04)

-3.88 (2.35)

0.08 (0.49)

1.42 (1.38)

Group#Time2

-

3

-

0.08 (0.75)

0.08 (0.08)

-

<0.01 (<0.01)

0.69 (0.53)

-0.01 (0.03)

-0.27 (0.32)

-

-

-0.01 (0.04)

-

-

<-0.01 (<0.01)

-0.03 (0.03)

-

0.01 (0.02)

Tourniquet

0.08 (0.35)

3.99 (4.34)

-0.05 (0.61)

0.83 (1.98)

-5.90 (1.98)

<-0.01 (<0.01)

-1.96 (1.36)

0.29 (0.46)

0.42 (0.60)

Baseline

0.22 (0.09)

1.80 (1.20)

0.45 (0.08)

0.35 (0.07)

0.57 (0.07)

0.33 (0.07)

0.45 (0.08)

0.27 (0.06)

0.34 (0.09)

Age

-0.10 (0.28)

-0.87 (2.87)

0.74 (0.37)

0.32 (1.28)

-0.62 (1.13)

0.01 (0.01)

-0.26 (1.01)

1.23 (0.32)

-0.40 (0.53)

Female Sex

0.03 (0.35)

5.82 (3.96)

-1.18 (0.53)

-5.24 (1.64)

-7.02 (1.95)

0.01 (0.02)

1.91 (1.26)

0.62 (0.44)

0.21 (0.58)

BMI

0.09 (0.17)

3.27 (2.15)

0.69 (0.34)

-1.70 (1.14)

-0.33 (0.92)

-0.03 (0.01)

-1.30 (0.64)

0.40 (0.24)

0.70 (0.37)

Previous TKA

-0.23 (0.37)

-3.53 (4.80)

-0.68 (0.51)

-1.58 (1.88)

0.63 (1.81)

0.01 (0.02)

-0.93 (1.24)

0.02 (0.42)

0.18 (0.66)

Intercept

3.20 (2.19)

23.68 (27.57)

46.93 (5.01)

23.01 (12.37)

41.56 (11.64)

-0.03 (0.12)

13.37 (9.83)

39.02 (4.31)

60.56 (6.24)

Group#Time

Group#Time

Abbreviations. SE = standard error.
*Bolded indicates significant at p<0.05.
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4.5.2.4 Change Results
Predicted pain decreased on average 0.24 points (95% CI -0.30, -0.18) in the midvastus
group and 0.26 points (95% CI -0.32, -0.19) in the standard group per week over the
course of the study (Figure 4-2). In the first two week after surgery, pain decreased on
average 1.26 points (95% CI -1.74, -0.78) in the midvastus group and 2.24 points (95%
CI -2.93, -1.55) in the standard group per day (Figure 4-3).

Figure 4-2. Separate fitted trajectories over time in weeks with 95% confidence intervals
for patient-reported pain over the 12-week study period for the standard (red) and
midvastus (blue) groups.
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Figure 4-3. Separate fitted trajectories over time in days with 95% confidence intervals
for patient-reported daily pain for the first two weeks after surgery for the standard (red)
and midvastus (blue) groups.

Predicted total TUG time decreased from discharge until week four (from 59.1 sec [95 %
CI 51.0, 67.2] to 9.0 sec [95% CI 6.2, 11.8] in the midvastus group and from 59.3 sec
[95% CI 51.9, 66.7] to 8.8 sec [95% CI 6.3, 11.3] in the standard group) then increased to
week 10 (24.7 sec [95% CI 20.2, 29.2] in the midvastus group and 24.5 sec [95% CI 21.3,
27.6] in the standard group) and finally decreased to week 12 (11.8 sec [95% CI 10.8,
12.8] in the midvastus group and 10.7 sec [95% CI 10.1, 11.4] in the standard group)
(Figure 4-4).
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Figure 4-4. Separate fitted trajectories over time in weeks with 95% confidence intervals
for total time to complete the Timed Up and Go test for the standard (red) and midvastus
(blue) groups.

Predicted motor power in the operative leg increased over the course of the study from
18.87 lb (95% CI 14.48, 23.27) at discharge to 39.44 lb (95% CI 36.43, 42.44) at 12
weeks in the midvastus group and from 19.62 lb (95% CI 16.13, 23.12) at discharge to
40.90 lb (95% CI 36.88, 44.93) at 12 weeks in the standard group (Figure 4-5). Predicted
motor power in the non-operative leg increased by 0.50 lb (95% 0.22, 0.78) in the
midvastus group and by 0.38 lb (95% CI 0.02, 0.73) in the standard group per week over
the course of the study (Figure 4-5).
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Figure 4-5. Separate fitted trajectories over time in weeks with 95% confidence intervals
for quadriceps strength for the operative (dashed lines) and non-operative (solid lines)
legs in the standard (red) and midvastus (blue) groups.

Predicted net speed increased early in the recovery period between discharge and week
six (from 0.13 m/s [95% CI 0.10, 0.16] to 0.74 m/s [95% CI 0.70, 0.79] in the midvastus
group and from 0.17 m/s [95% CI 0.15, 0.20] to 0.70 m/s [95% CI 0.67, 0.74] in the
standard group) and then remained constant until week 10 where net speed increased
again to 0.80 m/s (95% CI 0.76, 0.83) in the midvastus group and 0.79 m/s (95% CI 0.75,
0.83) in the standard group at week 12 (Figure 4-6).
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Figure 4-6. Separate fitted trajectories over time in weeks with 95% confidence intervals
for net speed in the standard (red) and midvastus (blue) groups.

In both groups, predicted stride length increased from discharge to week six (from 25.35
percent [95% CI 21.83, 28.86] to 56.87 percent [95% CI 54.46, 59.27] in the midvastus
group and from 27.25 percent [95% CI 24.45, 30.04] to 53.45 percent [95% CI 53.45
percent [51.08, 55.82]) (Figure 4-7). Stride length then decreased to week 10 in the
midvastus group (53.84 percent [95% CI 49.64, 58.03]) and in the standard group,
remained relatively constant until week nine. Stride length finally increased again in both
groups to 57.88 percent (95% CI 55.63, 60.15) in the midvastus group and 57.74 percent
(95% CI 55.60, 59.88) in the standard group at week 12.
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Figure 4-7. Separate fitted trajectories over time in weeks with 95% confidence intervals
for stride length in the standard (red) and midvastus (blue) groups.

Predicted single support time on the operative leg decreased from discharge to week eight
(from 68.35 percent [95% CI 65.89, 70.80] to 61.02 percent [95% CI 60.17, 61.86]) in the
midvastus group and from discharge to week nine (from 68.32 percent [95% CI 65.99,
70.64] to 61.21 percent [95% CI 60.41, 62.01]) in the standard group. Single support time
then increased slightly to 62.29 percent (95% CI 61.15, 63.43) in the midvastus group and
62.30 percent (95% CI 61.37, 63.24) in the standard group at week 12 (Figure 4-8).
Predicted single support time on the non-operative leg decreased from discharge to week
five (from 85.57 percent [95% CI 83.67, 87.46] to 64.14 percent [95% CI 62.82, 65.46] in
the midvastus group and from 84.38 percent [95% CI 82.30, 86.46] to 64.94 percent [95%
CI 63.73, 66.15] in the standard group), increased to week nine (68.12 percent [95% CI
65.96, 70.28] in the midvastus group and 67.32 percent [95% CI 65.09, 69.55] in the
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standard group) and then decreased again to week 12 (63.40 percent [95% CI 62.32,
64.48] in the midvastus group and 62.77 percent [95% CI 61.85, 63.69] in the standard
group) (Figure 4-8).

Figure 4-8. Separate fitted trajectories over time in weeks with 95% confidence intervals
for single leg support time for the operative (dashed lines) and non-operative (solid lines)
legs in the standard (red) and midvastus (blue) groups.

4.5.2.5 Regression Diagnostics
We observed linear relationships with time for patient-reported pain over the entire study
period, patient-reported pain within the first two weeks after surgery, and motor power on
the non-operative leg. Motor power and single support time on the operative leg both had
quadratic relationships with time. We observed cubic relationships with time for time to
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complete the TUG, net speed, stride length and single support time on the non-operative
leg. We found evidence to suggest variance in the intercept across participants for all
outcomes and evidence to suggest variance in the slopes across participants only for
patient-reported pain in the first two weeks after surgery.

4.6 Discussion
The purpose of our study was to compare the trajectory of functional recovery between
the midvastus and medial parapatellar surgical approaches within the first 12 weeks after
TKA. We identified only two outcomes with a significant group by time interaction
meaning that the trajectory of recovery differed significantly between the groups. Pain
recovery within the first two weeks after surgery was found to differ between the groups
with the midvastus group experiencing less pain immediately post-surgery, and the
standard group experiencing a steeper overall recovery. Both groups reported similar pain
by two-weeks postoperative. Recovery of stride length was also identified as differing
significantly between the groups with the midvastus group experiencing a steeper
recovery early in the post-surgery period, but both groups had similar stride length by the
end of the study period at 12 weeks post-surgery. All other outcomes measured displayed
similar trajectories of recovery for both groups and we found baseline values to be the
most consistent predictor of post-surgery values.

We identified a significant difference in the trajectory of recovery of patient-reported pain
within the first two weeks after surgery between the surgical approaches. The standard
group experienced more pain early in the recovery period and had a steeper recovery
compared with the midvastus group though both groups experienced similar pain at two
weeks post-surgery. Other studies have reported similar findings with patients undergoing
surgery with the midvastus approach experiencing less pain early in the recovery period
(3–5,10). Meta-analyses of randomized trials comparing the midvastus and medial
parapatellar approaches reported less pain with the midvastus surgical approach up to two
weeks post-surgery compared to the medial parapatellar approach. None of these studies
have reported differences in pain scores later than two weeks post-surgery (3–5). A recent
randomized trial by Aslam et al. (2017) compared the medial parapatellar and midvastus
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surgical approaches in 60 patients (84 knees) (10). They reported patients who underwent
surgery with the midvastus approach experienced significantly less pain at one day, one
week and one-month post-surgery. They also reported that these patients required less
narcotic medication on day one compared to those who had the medial parapatellar
approach used (10). Another recent randomized trial conducted by Feczko et al. (2016)
reported opposing results with the mini-midvastus group experiencing slightly more pain
at two weeks post-surgery compared to the medial parapatellar, though the difference was
small and likely not clinically important (mean difference 1.20 [95% CI 0.27, 2.12]) (11).
Similar to these studies, we did not find a difference in patient-reported pain when
looking at the trajectory of recovery over the entire study period out to 12 weeks postsurgery.

The only difference our study found in the trajectory of recovery of functional outcomes
was when looking at recovery of stride length between the two groups. We found the
midvastus group to experience more fluctuation in the trajectory of recovery of stride
length than the standard group with the standard group experiencing a slower initial
recovery, though both groups reached similar results by 12 weeks post-surgery. A
previous study by Wegrzyn et al. (2013) compared the medial parapatellar and minisubvastus surgical approaches in 37 patients (12). They reported improvements from preto post-surgery for gait outcomes including stride length, single-limb support and walking
speed, though no difference between the groups (12). Although the midvastus and
subvastus surgical approaches are not perfectly comparable, they should exhibit similar
results when compared with the medial parapatellar approach as both involve less
disruption of the extensor mechanism.

While we did not find a significant difference in the trajectory of recovery in regard to
time to complete the TUG test, this is similar to what has been reported in the literature.
A randomized trial conducted by Nutton et al. (2014) comparing the medial parapatellar
and midvastus surgical approaches in 28 patients also found no difference in TUG times
measured at six weeks, and three and six months (7). This study reported similar TUG
times at three months as our study with times of 9.5 seconds versus 11.5 seconds for the
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medial parapatellar approach and 11.4 seconds versus 11.3 seconds for the midvastus
approach. Also similar to our study, they reported no difference between the groups in
walking speed (7). Another study conducted by Yoshida et al. (2008) compared patients
who underwent surgery with the medial parapatellar surgical approach to matched,
healthy controls (13). They reported that TKA patients had TUG times equivalent to
healthy controls by 12 months post-surgery. They reported much lower TUG times at
three months than those found with our study, 7.33 seconds compared to 11.5 seconds in
our standard group. The TKA patients included in their study however, were both
younger (61.33 years versus 67.1 years) and had smaller BMIs (28.94 versus 32.4) (13)
than those included in our study which may help to explain this difference considering
that our study found both BMI and age to have a positive association with TUG time (as
BMI and age increases, so does time to complete the TUG).

Our study did not find a difference in the trajectory of recovery of quadriceps strength
between the groups. Two randomized trials which also compared quadriceps strength
between the medial parapatellar and midvastus approaches reported similar results with
no difference between groups up to six months post-surgery (7,11). While the trial by
Aslam et al. did not assess quadriceps strength directly, they reported that patients who
had the midvastus approach used during surgery achieved straight leg raise earlier than
those who had the medial parapatellar approach used (10). Though beyond the scope of
this study, Yoshida et al. showed an association between quadriceps strength and
functional outcomes including the time to complete the TUG test (13). They found that as
strength improved, so did TUG time. They also reported that operative leg quadriceps
strength was equivalent to that of the contralateral leg at 12 months, but remained weaker
than that of healthy matched controls (13). Wegrzyn et al. reported similar findings early
post-surgery with the operative leg remaining weaker than the contralateral leg at only
two months post-surgery, though improving significantly from pre-surgery, with no
differences between the groups (12). A longitudinal study conducted by Pua et al. (2017)
investigated factors associated with gait speed recovery after TKA (14). Similar to the
trial by Aslam et al., they reported that ipsilateral quadriceps strength was highly
predictive of gait speed, also with a positive association, as strength increased gait speed
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increased as well. They also identified age as a predictor of gait speed with a negative
association, as with increased age gait speed decreased (14). While our study did not find
age to be a significant predictor of net speed, it was found to be positively associated with
time to complete the TUG, with older participants taking longer to complete the TUG.
Pua et al. (2018), in a separate study, found similar trajectories of recovery for strength
and gait speed as those identified in our study, with steep improvements within the first 810 weeks after surgery, and then a more gradual improvement out to 16 weeks postsurgery (15).

A strength of this study was the factorial design as it has allowed us to investigate two
interventions by including all participants in both analyses. This design optimizes
efficiency and reduces the trial costs. Although, this paper only discusses the results of
the surgical approach intervention, future plans will be to analyze the other intervention
investigated as part of this factorial trial, tourniquet use. Our analysis of surgical approach
at the margins was appropriate in this study as we did not find a significant interaction
between surgical approach and tourniquet use when this was added into our analysis.

A limitation of our study is the cross-over rate. We had nine participants total cross-over
between the surgical approaches with seven participants crossing-over from the midvastus
group and two from the standard group. Although these numbers are concerning, the
primary analyses were performed according to the intention-to-treat principle, within the
group to which they were randomized. In addition, we performed an as treated analysis to
determine whether the cross-over rate had an impact on our results and found few
changes in our outcomes measured.

Another limitation with our study is the sample size. As the purpose of the study was to
inform the surgical protocol of a future randomized trial, we included the number of
patients we determined feasible to recruit within a two-year time frame to obtain a
preliminary understanding of functional recovery. While we were powered for some of
our included outcomes, pain within the first two weeks and stride length, we were clearly
underpowered for others. With a larger sample size, we may have had enough precision in
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our estimates to find a difference in the trajectory of recovery for more of our outcomes.
However, the trajectory of recovery of outcomes such as single support on the nonoperative leg, motor power on the non-operative leg and TUG time overlap so completely
(see Figures 4-4, 4-5 and 4-8) that an increase in sample size, and subsequent decrease in
the uncertainty is unlikely to find a difference between the groups.

4.7 Conclusions
Our study found the trajectory of recovery of pain within the first two weeks after surgery
and stride length to differ between the midvastus and medial parapatellar surgical
approaches. The midvastus group experienced less pain immediately post-surgery, and
the standard group experiencing a steeper overall recovery of pain. Both groups reported
similar pain by two-weeks post-surgery. For recovery of stride length, the midvastus
group experienced a steeper recovery early in the post-surgery period, but both groups
had similar stride length by the end of the study at 12 weeks post-surgery. Differences
were not found in any of the other functional outcomes measured. We found baseline
outcomes to be the most consistent predictor of post-surgery recovery. While neither
surgical approach was found to provide an advantage in the trajectory of recovery of most
functional outcomes measured, the difference in pain immediately after surgery may
suggest that the midvastus surgical approach could be advantageous for use in a future
large, randomized trial to investigate the safety and cost-effectiveness of outpatient TKA.
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Chapter 5: Discussion

5.1 Summary
The overall purpose of this dissertation was to explore factors related to reducing length
of stay after total joint arthroplasty (TJA). To achieve this purpose, we conducted three
studies. Study 1 was a preliminary analysis of a large randomized trial exploring the costeffectiveness of outpatient discharge compared with standard overnight stay in hospital
for total hip arthroplasty (THA). Standard overnight stay was dominated by outpatient
THA from both a healthcare payer and societal perspective as outpatient THA was both
more effective and less costly than standard overnight stay. Our net benefit regression
found outpatient THA to be cost-effective when compared with overnight stay from a
public healthcare payer perspective at all willingness-to-pay values, and from a societal
perspective, where indirect costs associated with the procedure such as time taken off
from paid employment, homemaking, volunteer and caregiving activities were taken into
consideration at willingness-to-pay values of $500 or greater. We also determined that
outpatient THA was cost-effective when patients’ caregiver’s time off was also included.
It’s important to note that while outpatient THA provided a statistically significant benefit
with a higher total WOMAC score at 12 weeks, the difference in effect we found between
the groups was not clinically important. As outpatient discharge was not anticipated to
provide a significant benefit 12-weeks post-surgery, these results could suggest additional
advantages that should be explored further.

Study 2 investigated which patient- and caregiver-related factors were associated with
caregiver strain and assistance when caring for patients undergoing TJA. We identified
the amount of caregiver assistance provided, patient sex and caregiver age to be
significantly predictive of caregiver strain with strain increasing as the amount of
assistance increases, and strain decreasing with increasing caregiver age. We also found
those caring for female patients to experience less strain than those caring for male
patients. When looking at factors related to the amount of assistance provided by
caregivers, we identified time, length of stay in hospital and patient and caregiver sex as
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being significantly predictive. We found caregivers to provide more assistance postsurgery compared to pre-surgery and for the amount of assistance provided to increase
with increasing length of stay in hospital. Female caregivers and those caring for female
patients were found to provide less assistance than male caregivers and those caring for
male patients.

Study 3 was also a randomized trial, with a 2x2 factorial design to compare the trajectory
of early functional recovery between two surgical approaches for total knee arthroplasty
(TKA); the medial parapatellar (standard) and midvastus. We identified only two
outcomes with a significant group by time interaction meaning that the trajectory of
recovery differed significantly between the groups. Pain recovery within the first two
weeks after surgery was found to differ between the groups with the midvastus group
experiencing less pain immediately post-surgery, and the standard group experiencing a
steeper overall recovery. Both groups reported similar pain by two-weeks postoperative.
Recovery of stride length was also identified as differing significantly between the groups
with the midvastus group experiencing a steeper recovery early in the post-surgery
period, but both groups had similar stride length by the end of the study period at 12
weeks post-surgery. We also identified baseline values as the most consistent predictor of
post-surgery outcomes.

5.2 Limitations
While the studies from this dissertation fill in some gaps within the existing literature,
there are limitations to the research that should be acknowledged. The results of Chapter
2 should be interpreted carefully as this was only a preliminary analysis of a larger
randomized trial. A larger, appropriately powered trial would be able to comment on the
true cost-effectiveness and safety of outpatient THA and reduce the uncertainty in our
estimates. While we found overnight stay to be dominated by outpatient THA for all
scenarios analyzed, the uncertainty around the estimates of cost include the possibility of
outpatient THA being more costly than overnight stay. A larger sample size that is able to
reduce the uncertainty in the estimates, would provide more confidence in our
conclusions.

91

With Chapter 3, though we had a large sample of caregivers and patients who
participated, our recruitment rate was only 54% although our recruitment rate was in
keeping with those reported in the literature, ranging between 35-60% (1–5). Improving
the recruitment rate would also help to improve the generalizability of study results as the
included sample will be more representative of the overall population. Along the same
vein, we also only included caregivers of patients who fit the stringent eligibility
requirements of our adjacent randomized trials. As such, we were only able to comment
on the strain and assistance provided to relatively healthy and independent patients, who
are likely not representative of the TJA population as a whole. Also, we recruited a
relatively small number of TKA caregivers to our study, only 19% of our sample were
caring for patients undergoing TKA. As TKA were not well represented in our sample,
it’s likely that our models may not represent caregivers of TKA patients as well as those
caring for THA patients. Finally, we only had caregivers complete the questionnaires at
two time points, prior to surgery and at two weeks post-surgery. For some patients, it’s
likely that their caregivers would need to be involved in their recovery for longer than
two weeks as not all patients may be completely independent at this point. While
investigating caregiver involvement very early after surgery is important, as it’s likely
when they are most involved, including further time points may be important to obtain a
clearer picture of how much assistance patients require over the entire recovery process
and the effects this may have on their caregivers.

For the study from Chapter 4, a limitation inherent with assessing gait and strength
outcomes so early after surgery is that not all participants are willing, or able to perform
the tests at all time points. As we saw from our discharge time point, 12% of participants
did not complete the Timed Up and Go (TUG) test and 42% of participants did not
complete the strength testing. Although our use of mixed effects models for our analyses
allowed us to accommodate this missingness, it’s important to take this into account when
designing future studies. The assessment of gait outcomes at discharge from hospital is
novel and interesting to consider but may not be practical in all populations. With this
study, we also had a high rate of cross-over between the groups. Though concerning, we
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followed the intention-to-treat principle in our primary analyses and performed an as
treated analysis as a sensitivity analysis.

5.3 Implications and Directions for Future Research
As much of the research in this dissertation was preliminary, results of the included
studies should be used to help guide future research. Our first study, in Chapter 2, has
shown that it’s possible to use blinding in a randomized trial to evaluate outpatient
arthroplasty. We were able to demonstrate a much lower cross-over rate compared to that
reported by Goyal et al. (2017), only 11% compared to 25% (6), likely due to our use of a
modified Zelen consent model (7), which reduces the risk of performance bias. Much of
the cross-over reported in Goyal et al.’s study was due to personal preference as their
participants were aware of the other study arm and had the option to switch groups (6).
While implementation of a modified Zelen consent model can complicate the research
process as participants are asked to reconsent to the use of their data at the end of the
study when they are fully informed of the deception (7), we demonstrated with our study
that only a small proportion of participants decline use of their data (n=1/106). Future
studies that wish to evaluate outpatient arthroplasty should consider using this model not
only to reduce the risk of participants crossing over due to personal preference, but also to
reduce the risk of bias associated with knowledge of the alternative study group.

As Chapter 2 presented the preliminary results of a larger randomized trial, future goals
should be to finish the recruitment and data collection for the complete study. More than
500 participants are aimed to be included which will provide a large enough sample to
estimate the safety of outpatient THA, as no previous prospective study has yet been
adequately power to make this determination. The goal should then be to assess the costeffectiveness of outpatient THA using adverse events as the measure of effect. As the rate
of serious adverse events after THA is low, ranging from 3.8-8.6% in the literature (8–
11), a large sample is required to ensure a sufficient number of events to assess whether
there is a difference between the two groups.
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A planned future study is to repeat the randomized trial from Chapter 2 in a population of
TKA patients in order to determine the safety and cost-effectiveness of outpatient TKA.
THA and TKA procedures and the populations of patients who undergo each may be
distinctly different and therefore the results of the full randomized trial from Chapter 2
may not be applicable for patients undergoing TKA. The results of our study from
Chapter 4 will help to inform the protocol for this study and whether or not to restrict the
surgical approaches used during the study. As we found no significant advantage in the
early post-operative period for the trajectory of recovery of the majority of gait outcomes
measured, there is support for allowing the use of either of the two surgical approaches to
be permitted for the study. As both of these surgical approaches are widely used, allowing
either approach to be used in the protocol will ensure the results of this study are
generalizable outside of our institution and not restricted to only those surgeons who use a
particular surgical approach in their practice. Also, as the study from Chapter 4 was a 2x2
factorial design, the effect of tourniquet use on the trajectory of recovery after TKA will
still need to be evaluated. Results from this analysis will also help to inform the protocol
of the next study, by providing evidence for whether or not tourniquet use should be
controlled in the protocol as well.

Surprisingly, we did not find length of stay to impact caregiver strain or assistance in the
way we had hypothesized in our study presented in Chapter 3. As a concern with reducing
length of stay in hospital is that care activities normally provided by healthcare
professionals may now need to be performed by patients and their caregivers at home, we
hypothesized caregivers who were caring for patients discharged earlier after surgery
would experience more strain and need to provide more assistance. We did not find
length of stay to be significantly related with caregiver strain. We found the amount of
assistance provided by caregivers to increase as length of stay increased (i.e. the longer a
patient stayed in hospital after surgery, the more assistance their caregiver provided).
While these results have yet to be validated, if true, future studies should consider
investigating this relationship further. Possible explanations for the relationship we found
between length of stay and caregiver assistance could be due to adverse events which
occurred while in hospital or in surgery that were not captured, slower recovery and
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progression with physiotherapy in hospital or other patient-related factors. While our
original model did include some patient-related factors which have been shown to be
related with length of stay after TJA, such as age, sex, BMI and comorbid status (12,13),
there could be other factors playing a mediating role in this relationship which future
research should explore.

Future research should also continue to make use of the Caregiver Assistance Scale
(CAS) to evaluate the amount of assistance provided by caregivers in various populations
of patients and establish a clinically important difference. Our study from Chapter 3
appears to be one of only three studies which have used this questionnaire (14,15). The
CAS was developed by Cameron et al. for use in studies to evaluate caregiver assistance
in populations of advanced cancer patients (14) and stroke survivors (15). In these
studies, the authors neglected to report the raw scores from the CAS and thus it is difficult
to assess the results we found in our study. Presumably, caregivers of elective TJA
patients provide less assistance than those caring for advanced cancer or stroke patients,
but we are unable to definitively state that at this time. As the CAS has not been well
used, a meaningful difference in score has yet to be determined. Future research is needed
to assess what constitutes a meaningful change in the amount of assistance provided for
caregivers when assessed with the CAS.

The predictors of caregiver strain and assistance we identified in our study in Chapter 3
should be validated in another large sample of caregivers of TJA patients. It would also
be important to repeat our study from Chapter 3 in a broader population of TJA patients,
as our study only included patients who were relatively healthy and independent, which is
not representative of the TJA population as a whole. To ensure results are generalizable to
the population, less stringent eligibility criteria should be explored. As stated previously,
it’s also important to include a larger proportion of caregivers of TKA patients, again to
improve the applicability of our results.
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5.4 Conclusions
This dissertation has shown that reducing the length of stay in hospital after TJA
procedures can be cost-effective, does not increase caregiver strain and is associated with
a reduction in the amount of assistance provided by caregivers. We have also provided
evidence for the use of either of two commonly used surgical approaches for TKA for a
future randomized trial to further explore outpatient arthroplasty. These results are
promising for their potential to reduce costs to the healthcare system, which continue to
increase with an aging population, and increase capacity in hospital for these procedures
by decreasing the amount of time beds are occupied without adversely affecting patients
or their families. While our results support the continued reduction in length of stay after
TJA procedures and performance of TJA as an outpatient procedure, it’s important to
consider that the studies included in this dissertation were mostly preliminary and thus
more research is required before changes in clinical practice are implemented.
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Appendix G. Cost Questionnaire for Study 1

Emergency Room Visits and Hospitalizations
1. Since your last visit, have you visited an emergency room for any reason?
q No – Skip to Question 2
q Yes – How many times?

If yes, which hospital did you go to and why?

1 Reason:
Hospital:
2 Reason:
Hospital:
2. Since your last visit, have you been admitted to the hospital overnight for any reason
(including overnight emergency room visits)?
q No – Skip to Question 3
q Yes – How many times?
Admission Date:

Please complete the following:
Discharge Date:

Days in ICU/CCU:
Major surgery /
procedure if any:
Reason:
Hospital:
Discharged to:
Family Doctor Visits
3. Since your last visit, have you seen your family doctor for any reason?
qI do not have a family physician - skip to Question 4
qI have not attended an appointment with my family physician since my last visit
(skip to Question 4)
qYes, I have attended an appointment with my family physician since my last visit.
Number of visits:
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Visit 1: Reason:
qCheck this box if the reason for visit was related to your hip replacement
Visit 2: Reason:
qCheck this box if the reason for visit was related to your hip replacement
Specialist Visits and Outpatient Clinics
4. Since your last visit, have you visited a specialist for any reason (please include visits to
the surgeon who performed your hip replacement)? If you are uncertain about the exact number
of visits, please provide your best estimate.
q No – Skip to Question 5
q Yes – Complete the following:
How many specialists? _______________
1:

Specialist Visited: ________________________________________________________
Number of Visits: ________________________________________________________
Please specify reason for visit: ______________________________________________

2:

Specialist Visited: ________________________________________________________
Number of Visits: ________________________________________________________
Please specify reason for visit: ______________________________________________

5. Since your last visit, have you visited any clinics for any reason (for example walk-in or
pain management clinics)? If you are uncertain about the exact number of visits, please provide
your best estimate.
q No – Skip to Question 6
q Yes – Complete the following:
Type of clinic visited

Reason for Visit

Number of
visits

Number of visits
relating to your hip
replacement?
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Other Health Care Professionals
6. Since your last visit, have you seen any other health professionals (like a physiotherapist,
occupational therapist, etc)? If you are uncertain about the exact number of visits, please
provide your best estimate.
q No – Skip to Question 7
q Yes – Complete the following:
Since your last visit, how many times have you visited a physiotherapist? ___________
Was this visit because
of your hip
replacement?

Cost of this
visit

How was the visit paid for?

qYes

qNo

$

qOHIP

qOut of pocket qPrivate insurance

qYes

qNo

$

qOHIP

qOut of pocket qPrivate insurance

qYes

qNo

$

qOHIP

qOut of pocket qPrivate insurance

qYes

qNo

$

qOHIP

qOut of pocket qPrivate insurance

Since your last visit, how many times have you visited an occupational therapist? _______
Was this visit because
of your hip
replacement?

Cost of this
visit

How was the visit paid for?

qYes

qNo

$

qOHIP

qOut of pocket qPrivate insurance

qYes

qNo

$

qOHIP

qOut of pocket qPrivate insurance

Since your last visit, how many other health professionals have you visited (for example a
chiropractor, massage therapist or community nurse)? ___________
Specialist

Number
of visits

Number of
visits related to
your hip
replacement?

Cost of
each visit

How was the visit paid for?

$

qOHIP qPrivate insurance
qOut of pocket

$

qOHIP qPrivate insurance
qOut of pocket

$

qOHIP qPrivate insurance
qOut of pocket
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Tests, Procedures, and Surgeries
7. Since your last visit, have you had any tests, procedures, or surgeries for any reason (for
example x-rays or blood tests)?
q No – Skip to Question 8
q Yes – Complete the following:
Test, procedure, or
surgery

Number
of tests

Number of tests
related to your
hip
replacement?

Where did you receive this test or
procedure?

qEmergency room

qHospital, inpatient

qHospital, outpatient

qRehab Centre

qOther, specify:
qEmergency room

qHospital, inpatient

qHospital, outpatient

qRehab Centre

qOther, specify:
Employment Status and Time-Off Work from Paid Employment
8. When you were enrolled in this study, were you actively employed?
q No - skip to Question 10
q Yes
9. Which of the following best describes your employment status or main activity at the
time of study enrollment?
q Employed (full time)
q Employed (part time)
q Homemaking
q Student
q Volunteer

q Social Assistance
q Retired
q Accident Insurance
q Government
q WSIB

q Litigation
q Disability
q Temporary Sick Leave
q Self-Employed
q Other: __________________

What was your occupation? _________________________________________
10. Has there been any change to your employment status since your last visit?
q No - skip to Question 11
q Yes – Please complete the following:
What is your current occupation? __________________________________________

130

11. Since your last visit, how much time off paid employment did you take off as a result of
your health? (includes hospitalization, doctor / emergency visits, treatment, and rehabilitation)
Days
Hours
qNone
12. What best describes your annual household income?
q <$20,000
q $20,000-$40,000
q $40,000-$60,000

q $60,000-$80,000
q $80,000-$100,000
q >$100,000
Homemaking and Volunteer Activities

13. Since your last visit, how much time off homemaking activities did you take off as a
result of your health (including hospitalization, doctor / emergency visits, treatment, and
rehabilitation)?
Days
Hours
qNone
14. Since your last visit, how much time off volunteer activities did you take off as a result
of your health (including hospitalization, doctor / emergency visits, treatment, and
rehabilitation)?
Days
Hours
qNone
15. This section is asking about your role as a primary caregiver.
Definition: Primary caregiver is an individual who is responsible for providing care
assistance, companionship, and/or supervision to another person.
Since your last visit,
q I have not been a primary caregiver - skip to Question 16
q I have been a primary caregiver. My role has NOT changed
If you had to take days off from primary caregiving, how many days did you take
off because of your hip (including hospitalizations, doctor visits, treatment and
rehabilitation)?
Days
Hours
qNone
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q I was a primary caregiver and now I am NO LONGER a primary caregiver
Date of change: |___|___|___|___|/|___|___|___|/|___|___|
yyyy
/
mmm / dd
Reason for no longer being a primary caregiver:

qI was NOT a primary caregiver and now I AM a primary caregiver
Date of change: |___|___|___|___|/|___|___|___|/|___|___|
yyyy
/
mmm / dd
Reason for becoming a primary caregiver:

How many days of primary caregiving did you provide?
Days
Hours
qNone
Assistive Living
16. Since your last visit, has there been a change to your living status? (for example, did you
move in with a relative, move into a rehabilitation facility or move back home?)
q No – Skip to Question 17
q Yes – Complete the following:
Is the change in living status related to your hip replacement?
q Yes q No – skip to Question 17
If yes, which option best describes the change in your living status:
q Living in own home – no hired assistance
Date Changed:
q Living in own home – hired assistance required
Date Changed:
Please indicate the source of funding and total charge.
q Publicly funded
$
q Insurance funded $
q Private funded
$
q Living in relative’s home – no hired assistance
Date Changed:
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q Living in relative’s home – hired assistance required
Date Changed:
Please indicate the source of funding and total charge.
q Publicly funded

$

q Insurance funded $
q Private funded

$

q Supportive housing / personal care home
Date Changed:
Type of assisted living:
q Assisted living (group home, retirement home)
q Residential care
q Long-term care facility, convalescent care, nursing home
Please indicate the source of funding and total charge.
q Publicly funded

$

q Insurance funded $
q Private funded

$

17. Did you incur any other expenses related to your hip replacement that we have not
asked you about? (e.g. gasoline, walking aids, meals, accommodation, parking, etc)
q No
q Yes – please specify, with approximate cost:
Expense:

$ cost:

Expense:

$ cost:

Expense:

$ cost:

Expense:

$ cost:
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Medications
18. Since your last visit, have you taken any prescription or over-the-counter medications
for your hip?
q No – Skip to Question 19
q Yes – Complete the following:
Yes
q

No
q

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Medication

Dose (mcg,
mg, g, other)

Pills/dose

Doses/day

How many
days?

Pills/dose

Doses/day

How many
days?

qAspirin
qCelebrex
qIndomethacin
qIbuprofen (Advil)
qDiclofenac (Arthrotec)
qMobicox (Meloxicam)
qNaproxen (Naprosyn)
qOther, specify:
Yes
q

No
q

Steroids (please list)

Name of steroid

Dose (mcg,
mg, g, other)
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Yes
q

No
q

Anti-Rheumatoid Drugs

Medication

Dose (mcg,
mg, g, other)

Pills/dose

Doses/day

How many
days?

Dose (mcg,
mg, g, other)

Pills/dose

Doses/day

How many
days?

qPlaquenil
(hydroxychloraquine)
qAralen (chloroquine)
qArava (Leflunomide)
qRheumatrex (Methotrexate)
qAzulfidine (Sulfasalazine)
qRemicade (Infliximab)
qEnbrel (Etanercept)
qHumira (Adalimumab)
qOther
Yes
q

No
q

Pain Killers

Medication
qTylenol Regular Strength
qTylenol Extra Strength
qTylenol 2, 3
qPercocets
qTramacet
qHydromorphone (Dilaudid)
qGabapentin
qLyrica
qOxycodone
qOther
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19. Since your last visit, did you take any other medications? Examples would include
antibiotics related to your hip replacement, or medications to prevent blood clots (i.e. Fragmin,
Xeralto, Pradaxa).
q No – Skip to Question 20
q Yes – Please record the name of the medication or D.I.N. number (Drug Identification
Number – found at the bottom of the prescription label on your medication bottle),
number of pills per dose, doses per day, start date of the medication, and end date for
each medication.
Medication
/DIN

Dose
(mcg, mg,
g, other)

Pills/d Doses/d
ose
ay

Start / End date

How did you pay for
this medication?

Start:

qOHIP
qPrivate insurance
qOut of pocket

End:
Start:
End:
Start:
End:
Start:
End:

qOHIP
qPrivate insurance
qOut of pocket
qOHIP
qPrivate insurance
qOut of pocket
qOHIP
qPrivate insurance
qOut of pocket

Assistance from Others
20. Since your last visit, have you received assistance from a relative or a friend for health
care, personal care, shopping, household activities, or transportation because of your
health?
q No
q Yes – Complete the following:
Health Care Activity

Number of
hours of
assistance

Assistance needed
because of hip
replacement?

qTaking Medications

qYes

qNo

qExercises / Rehab

qYes

qNo

q Other:

qYes

qNo

Number of hours off paid
employment
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Personal Care Activity

Number of
hours of
assistance

Assistance needed
because of hip
replacement?

q Dressing/Undressing

qYes

qNo

q Bathing/Showering

qYes

qNo

q Going to the bathroom

qYes

qNo

qGrooming (hair,
shaving)

qYes

qNo

Shopping/Home Activity

Number of
hours of
assistance

Assistance needed
because of hip
replacement?

q Shopping (groceries)

qYes

qNo

q Meal Preparation

qYes

qNo

q Housework

qYes

qNo

q Managing Finances

qYes

qNo

q Other:

qYes

qNo

Transportation to the…

Number of
hours of
assistance

Assistance needed
because of hip
replacement?

q Doctor

qYes

qNo

q Physiotherapist

qYes

qNo

q Bank

qYes

qNo

q Other:

qYes

qNo

Number of hours off paid
employment

Number of hours off paid
employment

Number of hours off paid
employment
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Appendix H. Caregiver Assistance Scale

CAS
We would like to know how much assistance you provide to the care recipient for each of the
following activities, a rating of zero (0) indicates “no” assistance is provided, while a rating of six
(6) indicates “a lot” is provided.
Please answer all questions to indicate your experience over the last two (2) weeks.
1.

How much assistance do you provide in transportation (e.g., to and from the hospital)?
None

2.

A Lot

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

⃝
6

A Lot

How much assistance do you provide in bathing?
None

9.

⃝
6

How much assistance do you provide in toileting (e.g., going to the bathroom)?
None

8.

⃝
5

How much assistance do you provide in grooming (e.g., combing hair, brushing teeth)?
None

7.

⃝
4

How much assistance do you provide in dressing?
None

6.

⃝
3

How much assistance do you provide in feeding?
None

5.

⃝
2

How much assistance do you provide in banking and financial management?
None

4.

⃝
1

How much assistance do you provide in giving medications/assisting with treatment?
None

3.

⃝
0

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

How much assistance do you provide in ambulation (e.g., walking, moving around the
home)?
None

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot
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10. How much assistance do you provide in transfers (e.g., bed to chair, chair to toilet)?
None

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

11. How much assistance do you provide in managing the emotional changes (e.g., crying
spells, mood changes)?
None

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

12. How much assistance do you provide in communication (e.g., helping with the telephone,
writing, reading, explaining things)?
None

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

13. How much assistance do you provide in coordinating, arranging, and managing services
and resources (e.g., scheduling appointments, arranging transportation, locating
equipment and services and finding outside help)?
None

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

14. How much assistance do you provide in communication with health professionals?
None

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

15. How much assistance do you provide in monitoring the health of the care recipient (i.e.
weight, blood pressure)?
None

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

16. How much assistance do you provide in household responsibilities (e.g., meal preparation,
cleaning, yard care)?
None

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot

17. How much assistance do you provide in managing behavior problems of care recipient
(e.g., irritability, irrational thoughts)?
None

⃝
0

⃝
1

⃝
2

⃝
3

⃝
4

⃝
5

⃝
6

A Lot
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Appendix I. Caregiver Strain Index

Caregiver Strain Index
This is a list that other caregivers have found to be difficult. Would you please
answer the following questions and identify if any of these applied to you over
the last 2 weeks?
Sleep is disturbed (e.g., because _____is in and out of bed or wanders
around at night)
It is inconvenient (e.g., because helping takes so much time or it is a
long drive over to help)
It is a physical strain (e.g., because of lifting in and out of a chair;
effort or concentration is required)
It is confining (e.g., helping restricts free time or cannot go visiting)
There have been family adjustments (e.g., because helping has
disrupted routine; there has been no privacy)
There have been changes in personal plans (e.g., had to turn down a
job; could not go on vacation)
There have been other demands on my time (e.g., from other family
members)
There have been emotional adjustments (e.g., because of severe
arguments)
Some behavior is upsetting (e.g., because of incontinence; _____ has
trouble remembering things; or _____accuses people of taking
things)
It is upsetting to find _____ has changed so much from his/her former
self (e.g., he/she is a different person than he/she used to be)
There have been work adjustments (e.g., because of having to take
time off) It is a financial strain
Feeling completely overwhelmed (e.g., because of worry about ____;
concerns about how you will manage)

Yes
⃝

No
⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝

⃝
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release on gait after direct anterior total hip arthroplasty. Hip International. 2019
Nov;29(6):578-583. Principal author
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Simunovic N, Heels-Ansdell D, Thabane L, Ayeni OR, FIRST Investigators.
Femoroacetabular Impingement Randomised controlled Trial (FIRST) - a multi-centre
randomized controlled trial comparing arthroscopic lavage and arthroscopic
osteochondroplasty on patient important outcomes and quality of life in the treatment of
young adult (18-50 years) femoroacetabular impingement: a statistical analysis plan.
Trials. 2018 Oct 29;19(1):588. Member of FIRST Investigators
Zomar BO, Bryant D, Hunter S, Howard JL, Vasarhelyi EM, Lanting BA. A randomized
trial comparing spatio-temporal gait parameters after total hip arthroplasty between the
direct anterior and direct lateral surgical approach. Hip International. 2018
Sep;28(5):478-484. Principal author
Anderson DR, Dunbar M, Murnaghan J, Kahn SR, et al. Aspirin or rivaroxaban for VTE
prophylaxis after hip or knee arthroplasty. New England Journal of Medicine. 2018
Feb;378:699-707. Collaborator
INVITED SPEAKER
A Randomized Trial to Investigate the Cost of Outpatient Total Hip Arthroplasty
• Feb 2020, Collaborative Program in Musculoskeletal Health Research/British
Orthopaedic Research Society Fellows Trainee Seminar, Western University,
London, ON
Lab SOPs and Data Management
• May 2019, Collaborative Program in Musculoskeletal Health Research (CMHR)
Summer Lunch Seminar Series, Western University, London, ON
Health Quality Arthroplasty Research Update
• May 2018, 2018 Hip and Knee Arthroplasty Symposium, London Health Sciences
Centre, London, ON
PODIUM PRESENTATIONS
A randomized trial investigating the cost-utility of patient specific instrumentation in
total knee arthroplasty in an obese population
Zomar B, Vasarhelyi E, Somerville L, Lanting B, Howard J, Marsh J
• Jun 2020, Canadian Orthopaedic Association 75th Annual Meeting, Halifax, NS –
conference moved online, changed to e-poster
• Jun 2020, 21st EFORT Annual Congress, Vienna, Austria – conference cancelled
A randomized trial to investigate the cost of outpatient total hip arthroplasty
Zomar B, Marsh J, Bryant D, Lanting B
• Jun 2020, Canadian Orthopaedic Association 75th Annual Meeting, Halifax, NS –
conference moved online, changed to e-poster
• Mar 2020, American Academy of Orthopaedic Surgery 2020 Annual Meeting,
Orlando, FL – conference cancelled
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• Feb 2020, Health & Rehabilitation Sciences Graduate Research Conference,
Western University, London, ON
A randomized control trial to investigate the cost-effectiveness of outpatient total hip
arthroplasty
Zomar B, Marsh J, Bryant D, Lanting B
• Jun 2019, 20th EFORT Annual Congress, Lisbon, Portugal
• Sep 2019, The Hip Society 2019 Summer Meeting, Kohler, WI (Presented by Dr.
James Howard)
A randomized trial investigating the cost-effectiveness of patient specific instrumentation
in total knee arthroplasty in an obese population
Zomar B, Vasarhelyi E, Somerville L, Lanting B, Howard J, Marsh J
• Jun 2019, Canadian Orthopaedic Association 74th Annual Meeting, Montreal, QC
Perioperative gait analysis after total hip arthroplasty: Does outpatient surgery
compromise patient outcomes?
Zomar B, Bryant D, Hunter S, Howard J, Lanting B
• Mar 2018, American Academy of Orthopaedic Surgery 2018 Annual Meeting,
Global Perspectives Paper Session, New Orleans, LA
• Mar 2018, American Academy of Orthopaedic Surgery 2018 Annual Meeting,
Adult Reconstruction Hip II Paper Session, New Orleans, LA
• Feb 2018, Health & Rehabilitation Sciences Graduate Research Conference,
Western University, London, ON
Functional Recovery after Total Hip Arthroplasty: Direct Anterior versus Direct Lateral
Surgical Approach
Zomar B, Bryant D, Hunter S, Howard J, Vasarhelyi E, Lanting B
• Mar 2018, American Academy of Orthopaedic Surgery 2018 Annual Meeting,
Adult Reconstruction Hip II Paper Session, New Orleans, LA (Presented by Dr.
Brent Lanting)
Implementation of Outpatient Total Joint Arthroplasty in Ontario: Where We Are and
Where We Need to Go
Zomar B, Sibbald S, Bickford D, Howard J, Bryant D, Marsh J, Lanting B
• Feb 2018, Health & Rehabilitation Sciences Graduate Research Conference,
Western University, London, ON
A prospective cohort study investigating functional recovery after total hip arthroplasty
for patients with osteoarthritis using a direct anterior versus direct lateral surgical
approach
Zomar B, Bryant D, Hunter S, Howard J, Vasarhelyi E, Lanting B
• Jun 2016, Canadian Orthopaedic Association 71st Annual Meeting, Quebec City,
QC
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A prospective cohort study investigating functional recovery after total hip arthroplasty
for patients with osteoarthritis using a direct anterior versus direct lateral surgical
approach: A preliminary analysis
Zomar B, Bryant D, Hunter S, Howard J, Lanting B
• Nov 2015, Canadian Arthroplasty Society 4th Annual Meeting, Ottawa, ON
(Presented by Dr. James Howard)
• May 2015, Bodies of Knowledge Graduate Student Conference, University of
Toronto, Toronto, ON
Functional recovery from total hip replacement: direct anterior approach (DAA) versus
direct lateral approach (DLA)
Zomar B, Bryant D, Hunter S, Howard J, Lanting B
• May 2014, Bodies of Knowledge Graduate Student Conference, University of
Toronto, Toronto, ON
• Apr 2014, 3-Minute Thesis Competition, Western University, London, ON
POSTER PRESENTATIONS
Early outcomes of patient specific instrumentation total knee arthroplasty in an obese
population
Zomar B, Kooner P, Somerville L, Marsh J, Lanting B, Howard J, Vasarhelyi E
• Jun 2020, Canadian Orthopaedic Association 75th Annual Meeting, Halifax, NS
(Presented by Dr. Paul Kooner) – conference moved online, changed to e-poster
• Jun 2019, 20th EFORT Annual Congress, Lisbon, Portugal
A randomized trial investigating the cost-effectiveness of patient specific instrumentation
in total knee arthroplasty in an obese population
Zomar B, Vasarhelyi E, Somerville L, Lanting B, Howard J, Marsh J
• Jun 2019, 20th EFORT Annual Congress, Lisbon, Portugal
A randomized trial to investigate the cost-effectiveness of outpatient total hip arthroplasty
Zomar B, Marsh J, Bryant D, Lanting B
• Apr 2019, London Health Research Day, London, ON
Perioperative gait analysis after total hip arthroplasty: Does outpatient surgery
compromise patient outcomes?
Zomar B, Bryant D, Hunter S, Howard J, Lanting B
• May 2018, Canadian Bone and Joint Conference, Western University, London,
ON
• Mar 2018, Western Research Forum, Western University, London, ON
A prospective cohort study investigating functional recovery after total hip arthroplasty
for patients with osteoarthritis using a direct anterior versus direct lateral surgical
approach: A preliminary analysis
Zomar B, Bryant D, Hunter S, Howard J, Lanting B
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• Apr 2016, Canadian Bone and Joint Conference, Western University, London,
ON
• Apr 2015, Kinesiology Graduate Student Association Symposium, Western
University, London, ON
• Mar 2015, Faculty of Health Science Research Day, Western University, London,
ON
You Snooze, You Lose! Does a shorter sleep duration lead to obesity?
Panasar M, Zomar B
• Mar 2013 – 4th Annual TRU Respiratory Health & Sleep Science Conference,
Thompson Rivers University, Kamloops, BC
PROFESSIONAL DEVELOPMENT
Mar 2020

Managerial Accounting, Ivey Training Workshop, with Chris
Sturby

Oct 2019

Introduction to Negotiations for Leaders, Ivey Training
Workshop, with Dr. Fernando Olivera

Oct 2018

Canada Good Clinical Practice (GCP), Collaborative
Institutional Training Initiative (CITI Program)

Oct 2018

Introduction to Decision Analytics, Ivey Training Workshop,
with Dr. Lauren Cipriano

Jun 2018

Standard Operating Procedures for Clinical Research, Lawson
Health Research Institute

May 2018

Introduction to Financial Accounting, Ivey Training Workshop,
with Mary Gillett

Nov 2017

Health Systems Structure and Trends, Ivey Training Workshop,
with Vania Sakelaris

Apr 2017

Small & Medium Enterprises - Building the Case for
Commercialization & Venture Capital Investment, Ivey
Training Workshop, with Dr. Brent Norton

Mar 2014

Tri-Council Policy Statement: Ethical Conduct for Research
Involving Humans (TCPS2)

TEACHING ASSISTANTSHIPS
Jan – Apr 2018

Design of Introductory Research Methods Course, Western
University, with Dr. Dianne Bryant
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Jan – Apr 2018

Special Topics in Health Promotion: Environmental Health
Promotion, Western University, with Dr. Denise Grafton

Sep – Dec 2017

Mental Illness and Healing – Transcultural Perspectives, Western
University, with Dr. Elysée Nouvet

Jan – Apr 2017

Special Topics in Health Promotion: Environmental Health
Promotion, Western University, with Dr. Jeannie Samuel

Jan 2014 – Apr 2015

Systemic Approach to Functional Anatomy, Western University,
with Drs. Jamie Melling and Graham Fraser

Sep – Dec 2013

Introductory Biomechanics – A Qualitative Approach, Western
University, with Dr. Bob Vigars

VOLUNTEER EXPERIENCE
June 2020

Poster Judge, Canadian Bone and Joint Conference 2020,
Western’s Bone and Joint Institute, Western University, London,
ON

May 2020

Abstract Review, Canadian Bone and Joint Conference 2020,
Western’s Bone and Joint Institute, Western University, London,
ON

Jan 2014 – Nov 2019

Subject, Various Master of Physiotherapy Clinical Exams,
Western University, London, ON

Feb 2016 – Oct 2019

Supervise Work Study/Volunteer Students, Western University,
London, ON

Dec 2017, 2018, 2019 Abstract Review, Health & Rehabilitation Sciences Graduate
Research Conference, Western University, London, ON
Apr 2019

Poster Judge, London Health Research Day, London, ON

Feb 2018

Conference Preparation and Set Up, Health & Rehabilitation
Sciences Graduate Research Conference, Western University,
London, ON

Jul 2017

Poster Judge, Master of Physiotherapy Research Day, Western
University, London, ON

Nov 2013 – May 2017 Study Participant, Various Master’s and PhD Projects, Western
University and London Health Sciences Centre, London, ON
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Apr 2016, 2017

Oral and Poster Presentation Judge, Kinesiology Graduate
Student Association Symposium, Western University, London,
ON

Jun 2014 – Aug 2015

Kinesiology Representative, Society of Graduate Students,
Western University, London, ON

Feb 2014 – Jul 2015

Blood Pressure Clinics, Victorian Order of Nurses Canada,
London, ON

Feb 2014 – Jul 2015

Community Events, Let’s Talk Science, London, ON

Mar 2015

Registration, Technology in Education Symposium 2.0, Western
University, London, ON

Sep 2011 – May 2013 Active Member and Treasurer (2012/13), Biology Undergraduate
Society, Thompson Rivers University, Kamloops, BC
Mar 2013

Registration and Room Overseer, 8th Annual TRU
Undergraduate Student Research & Innovation Conference,
Thompson Rivers University, Kamloops, BC

Mar 2012 & 2013

Adjudicator, Wild West Fest Gymnastics Competition,
Kamloops Gymnastics and Trampoline Centre, Kamloops, BC

Feb – Dec 2012

Waiting Area Attendant, Intensive Care Unit, Royal Inland
Hospital, Kamloops, BC

Oct 2009, 2010, 2012

Set-Up, CIBC Run for the Cure, Canadian Breast Cancer
Foundation, Kamloops, BC

Sep – Dec 2010

Assistant Coach, Wolfpack Cheerleading Team, Thompson
Rivers University, Kamloops, BC

Jul – Aug 2010

Summer Staff (Challenge Courses), YoungLife Canada,
Rockridge Canyon, Princeton, BC

HONOURS & AWARDS
2019 – 2020

Ontario Graduate Scholarship, $15,000, Western University

2018 – 2019

Ontario Graduate Scholarship, $15,000, Western University

2016 – present

Western Graduate Research Scholarship, Western University
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2018

Collaborative Program in Musculoskeletal Health Research
Trainee Stipend, $600, Western University

2017

Collaborative Program in Musculoskeletal Health Research
Trainee Stipend, $750, Western University

2017

Staff Award of Excellence, Lawson Impact Awards, with the
Arthroplasty Research Team, $1000, Lawson Health Research
Institute

2015

Kinesiology Graduate Travel Award, $400, Western University

2013 – 2015

Western Graduate Research Scholarship, Western University

2014

Faculty of Health Science Travel Award, $400, Western
University

2009 – 2013

Dean’s List, Faculty of Science, Thompson Rivers University

CERTIFICATIONS
2012

NCCP Level 2 Artistic Gymnastics, Level 1 Trampoline

9

